Microorganisms 12 00121 v2
Microorganisms 12 00121 v2
Microorganisms 12 00121 v2
Review
The Evolving Microbiome of Dental Caries
Grace Spatafora 1, * , Yihong Li 2 , Xuesong He 3 , Annie Cowan 4 and Anne C. R. Tanner 3, *
Abstract: Dental caries is a significant oral and public health problem worldwide, especially in low-
income populations. The risk of dental caries increases with frequent intake of dietary carbohydrates,
including sugars, leading to increased acidity and disruption of the symbiotic diverse and complex
microbial community of health. Excess acid production leads to a dysbiotic shift in the bacterial
biofilm composition, demineralization of tooth structure, and cavities. Highly acidic and acid-tolerant
species associated with caries include Streptococcus mutans, Lactobacillus, Actinomyces, Bifidobacterium,
and Scardovia species. The differences in microbiotas depend on tooth site, extent of carious lesions,
and rate of disease progression. Metagenomics and metatranscriptomics not only reveal the structure
and genetic potential of the caries-associated microbiome, but, more importantly, capture the genetic
makeup of the metabolically active microbiome in lesion sites. Due to its multifactorial nature, caries
has been difficult to prevent. The use of topical fluoride has had a significant impact on reducing
caries in clinical settings, but the approach is costly; the results are less sustainable for high-caries-risk
individuals, especially children. Developing treatment regimens that specifically target S. mutans
and other acidogenic bacteria, such as using nanoparticles, show promise in altering the cariogenic
microbiome, thereby combatting the disease.
excessive consumption of sugar and dental caries and documents the many dimensions of
disparities and financial burdens in dental caries [3].
Furthermore, the global burden of disease suggests that dental caries and untreated
caries are responsible for more than 26% of the total dental disease burden and 2.7 million
disability-adjusted life years which cost over 172 billion U.S. dollars to treat [4]. On a
national level, the U.S. spent over $110 billion in 2016 on dental visits [5], of which over
60% was directed toward treating dental caries. Many high-income countries have a lower
disease burden caused by fermentable mono- and disaccharide [MDS]-related dental caries
than most middle- and low-income countries [6] and disadvantaged populations and
nations with limited access to caries prevention and treatment. Untreated caries can cause
pain and infection, impairment of dental function, tooth mortality, missing school hours,
and productivity losses. Thus, dental caries remains a serious public health issue with
substantial long-term health, economic, and societal impact due to the persistently high
prevalence and excessive treatment costs. The disease negatively affects general health and
oral health-related quality of life for all age groups [7,8], including infection, impairment of
dental function, tooth mortality, missing school hours, and productivity losses. Overall,
dental caries remains a serious challenge with substantial long-term health, economic, and
societal impact due to its persistently high prevalence and excessive treatment costs [7,8].
In this review, we probe the epidemiology of dental caries and its association with
diet. We delve into the history of caries, ecology-based theories about the role of bacteria
in caries, and their association with the development of the oral microbiome as a biofilm.
We examine the microbiotas associated with enamel and dentin caries and aggressive
diseases with the functional activity of bacterial communities. Using an advanced map of
the caries microbiome, we explore new control and treatment strategies for modulating
disease-associated microbial dysbiosis and the role of therapeutics in alleviating caries and
re-establishing a healthy microbiota in the human mouth. The review is based on literature
searches in the categories of caries microbiology, epidemiology, etiology, and treatment.
2. Background
2.1. Epidemiology of Dental Caries
As a bacteria-mediated, sugar-driven, and oral-hygiene-modified dynamic disease,
dental caries persists as one of the most common chronic diseases affecting the general
population of all age groups. Worldwide, the estimated average prevalence of dental
caries of deciduous teeth in 2019 was 43% (38% in high-income countries and 46% in low-
income counties) [9]. It is estimated that 514 million children suffer from untreated caries
in deciduous teeth worldwide. The estimated age-standardized prevalence of dental caries
in permanent teeth was 29.4%, and 2.3 billion adults had untreated caries in permanent
teeth [4,10,11].
There has been a decrease in caries in younger age groups in selected regions over the
last few decades due to community water fluoridation [12–15], the widespread availability
of fluoride toothpaste [16], reduced sugar intake [17], and increased access to oral health
services [18]. In the United States, caries rates slightly decreased in the primary teeth of
2- to 5-year-old children but not in the permanent teeth of 6- to 11-year-old adolescents
between 1988 and 2016 (Figure 1A) [19–21]. These downward trends, however, were not
observed in many low- or middle-income nations when associated with increased sugar
consumption during that time period [22].
There were no significant changes in overall caries status in adults aged 20 to 64 years,
but a notable increase in older American adults over 65 years [19–21] (Figure 1B). World-
wide, billions of people with untreated caries have significantly and dramatically increased
the burden on healthcare systems [23]. One contributing factor is an increase in life ex-
pectancy, leading to more older people maintaining their teeth, which has an associated
caries burden [19–21,24,25]. This challenges the healthcare system everywhere, particularly
in low- and middle-income countries.
Microorganisms 2024, 12, 121 3 of 47
Microorganisms 2024, 12, 121 sociated caries burden [19–21,24,25]. This challenges the healthcare system everywhere,
3 of 45
particularly in low- and middle-income countries.
Figure
Figure1.1.TheThedistribution
distributionofofdental
dentalcaries
cariesby
byage,
age,race,
race,and
andethnicity,
ethnicity,and
andfamily
familyincome
incomeininthe
theU.S.
U.S.
population.
population.(A) (A)Prevalence
Prevalenceof ofcaries
cariesininprimary
primaryteeth.
teeth. Compared
Comparedwith withNHANES
NHANES1988–1994,
1988–1994,caries
caries
experience
experience slightly decreasedfor
slightly decreased forchildren
children2-2-
to to 5-year-olds.
5-year-olds. However,
However, the the decrease
decrease was was not ob-
not observed
served
for 6- to 8-year-old children between 1988 and 2016. (B) Trend in dental caries. There was awas
for 6- to 8-year-old children between 1988 and 2016. (B) Trend in dental caries. There a
slight
slight decrease in caries experience in the permanent dentition of young children and adolescents
decrease in caries experience in the permanent dentition of young children and adolescents between
between 1988 and 2016. However, there are no significant changes in overall caries status in adults
1988 and 2016. However, there are no significant changes in overall caries status in adults aged
aged 20 to 64 years old. Caries prevalence significantly increased for the elderly aged 64 years and
20 to(C–E)
over. 64 years old. Caries
Prevalence prevalence
of caries significantly
in primary increasedteeth
and permanent for the elderly aged
in 2011–2016 by 64
ageyears and over.
(C), race and
ethnicity (D), and family poverty status, FPL = Federal Poverty Level (E). (F–H) Prevalenceethnicity
(C–E) Prevalence of caries in primary and permanent teeth in 2011–2016 by age (C), race and of un-
(D), andcaries
treated family bypoverty
age (F),status,
race andFPLethnicity,
= FederalNHisp
Poverty= Level (E). (F–H)(G),
Non Hispanic Prevalence of untreated
and family poverty caries
level
(FPL)
by age(H)(F),inrace
the U.S. population.
and ethnicity, NHisp = Non Hispanic (G), and family poverty level (FPL) (H) in the
U.S. population.
The National Health and Nutrition Examination Survey 2015–2016 data reported
Theprevalence
that the National Health
of dental and Nutrition
caries Examination
in permanent Survey 2015–2016
teeth increased with age data
fromreported
9.5% to
that the prevalence of dental caries in permanent teeth increased
96% (Figure 1C) [9]. Significant socioeconomic inequalities exist in caries experience with age from 9.5%
and
to 96% (Figure
untreated caries1C)
in [9]. Significant
children socioeconomic
and adults. Hispanicinequalities
youth andexist adultsin caries experience
experienced the
and untreated
highest caries
prevalence of in children
total and adults.
caries (32.9% at 2–5Hispanic
years old,youth
72.8% and adults
at 6–8 experienced
years old, 69.7%the
at
highest prevalence of total caries (32.9% at 2–5 years old, 72.8%
12–19 years old, and 86.6% at 20–64 years old) compared with other ethnic groups [9]at 6–8 years old, 69.7%
at 12–191D).
(Figure years
Theold, and 86.6%
prevalence at 20–64
was higheryears
among old) compared
poor with other
and near-poor ethnicand
children groups [9]
adults
(Figure 1D). The prevalence was higher among poor and near-poor
than in non-poor counterparts (Figure 1E). Among millions of American children and children and adults
than in16.4%
adults, non-poor
of 6- counterparts (Figure 1E).
to 8-year-old children andAmong
more than millions
25% ofof20-American children
to 74-year-old and
adults
adults, 16.4% of 6- to 8-year-old children and more than 25% of 20-
had at least one untreated decayed tooth (Figure 1F). Non-Hispanic black populations to 74-year-old adults
had the
had at least one untreated
highest prevalencedecayed tooth (Figure
of untreated caries in1F). Non-Hispanic
primary black populations
teeth (22.4%) and permanent had
the highest prevalence of untreated caries in primary teeth (22.4%)
teeth (40.2%) (Figure 1G). The prevalence increased for both total caries and untreatedand permanent teeth
(40.2%)
caries as(Figure 1G). Thelevels
family income prevalence
decreasedincreased for both
[9,19,26–28] total caries
(Figure 1H). and untreated caries as
family income levels decreased [9,19,26–28] (Figure 1H).
For a long time, the caries diagnosis and risk assessment methods used in epidemi-
For a long time, the caries diagnosis and risk assessment methods used in epidemi-
ologic studies varied worldwide, resulting in different outcomes for reporting, evaluat-
ologic studies varied worldwide, resulting in different outcomes for reporting, evaluat-
ing, and monitoring disease progression. Many government-funded water fluoridation
programs or caries risk assessment programs measured caries management using a risk
Microorganisms 2024, 12, 121 4 of 45
of plaque pH to below 5.5, as this was considered the level of acidity needed for enamel
demineralization. Marked differences in plaque acid responses were observed based on
caries clinical status including caries-free, slight caries, obvious lesions, and aggressive,
advanced lesions. In caries-free subjects, post-glucose rinse acidity remained above pH 5.5,
suggesting no enamel demineralization. By contrast, in aggressive caries, the initial resting
plaque acidity was below that needed for demineralization, with further lowering after the
glucose challenge to under a pH of 4.
But how do sugars, particularly sucrose and fructose, impact the rate of caries de-
velopment? As a metabolite for caries-associated pathogens, sucrose is easily converted
into its monosaccharide constituents, glucose and fructose, each of which can serve as sub-
strates for bacterial fermentation to produce lactic acid byproducts [45]. The combination
of acid-producing bacteria and fermentable carbohydrates, some of which can be stored as
intracellular polysaccharide, fosters continuous exposure of the host dentition to organic
acids for extended periods, including non-meal times [46]. Thus, to understand the impact
of the cariogenic process on caries development and treatment, we must understand these
and other players that contribute to the caries phenotype.
Host-based caries risk factors, including genetics, stress, and access to fluoridated
water, have evolved over time and/or remain disparate for individuals of different socio-
economic strata [32]. Populations that cannot afford or have limited access to healthy
foods are at higher risk for dental caries. Increasing disease incidence among the socioe-
conomically disadvantaged derives primarily from host genetics and individual dietary
intake [47]. While genetic host-based risk factors can impact the expression of salivary
proteins in the tooth pellicle [48,49], dietary risk factors can be related to medications,
exposure to environmental toxins, or systemic disease that can weaken tooth structure
and resistance to bacterial acid attack. The mechanisms that underlie these risk factors are
frequently related to the ability of bacteria to attach to teeth or the resistance of teeth to
acidity and demineralization. Bacterial attachment to teeth via the pellicle is a critical step
in caries formation, as it encourages subsequent biofilm development. This attachment
can be greatly facilitated on the rough surfaces of poorly formed enamel, for example in
individuals with genetically determined amelogenesis imperfecta and other conditions
leading to tooth malformations.
ability to study and characterize the healthy oral microbiome is essential for understanding,
diagnosing, and treating diseases of the human oral cavity, including dental caries.
Since the first publication of a human metagenomic study in 2006 [54], the field of
human microbiome research has exploded. Microbiome research in the 21st century has
incorporated research into the dynamic relationship between the oral microbiome and the
host environment in health and disease. The total number of manuscripts published in the
field of oral health versus the caries-associated microbiome by international researchers has
increased markedly in recent years. A substantial “core model” comprised of approximately
60% of the oral taxa has been suggested to contribute to the deleterious shift in bacterial
diversity to acidic (cariogenic) from neutral (healthy) pH environments [55].
a highly cariogenic high-sucrose diet [61]. Paul Keyes then expanded the importance of
bacteria in caries in a series of studies using Syrian hamsters and other animals. Keyes
summarized many of his experiments in a 1960s publication [62], where he reported that
caries could be transferred from animals with caries to those with no lesions. Keyes also
noted that, in young weanlings, the source of the caries bacteria was transmitted from
the mother. Furthermore, Keyes observed that taking plaque from caries in one animal
could induce caries in non-diseased animals, and that antibiotic administration inhibited
lesions from developing. Caries was also suppressed in pups from mothers with lower
caries experience [62]. In collaboration with Fitzgerald, Keyes reported that the bacterium
responsible for experimental caries was an acidogenic streptococcus [63], which Keyes
observed could by itself induce caries in germ-free animals. It was not until the late 1960s
that Edwardsson made the discovery that the S. mutans he isolated from humans was the
same species that Keyes described from carious lesions in experimental animals, and also
the same species that was described by Clarke in 1924 [64]. Numerous clinical studies have
demonstrated the strong association between S. mutans and dental caries [65–68]. Hence,
the concept of a key role for S. mutans in dental caries was established.
The development of a caries-associated microbiome was subsequently described using
an ecological plaque hypothesis [69]. This concept was based, in part, on chemostat studies
and the growth of a mixture of nine oral bacteria pulsed with glucose at different pHs
over time [70]. The experimental findings indicated that when a healthy resting oral
pH of 7.0 was maintained, Streptococcus gordonii, which is acidogenic but not very acid-
tolerant, dominated the community. When the acidity of the medium was not controlled in
the experiment, however, the pH dropped to 4.5 and the acid-tolerant species S. mutans,
Lactobacillus casei, and Veillonella dispar dominated the community [70]. According to this
model, the metabolism of all acid-producing species in the nine-species cocktail lowered the
environmental pH, but only the acid-tolerant species could survive. Thus, the oral biofilm
under acid stress undergoes a selective succession that favors acid-tolerant species. In
accordance with the ecological plaque hypothesis, it is dietary carbohydrates, particularly
sucrose, that are the drivers of acid production in tooth-associated microbial communities.
Consistent with this hypothesis are the noticeable shifts in biofilm architecture and microbial
population dynamics that were observed after the consumption of a meal [71].
Figure 2.2.Major
Figure Majorspecies
species identified
identified from
from caries-free
caries-free sites,sites,
enamelenamel
caries,caries, and dentin/root
and dentin/root caries.
caries. Shown
Shown
are crossare cross sections
sections of the dentin,
of the enamel, enamel,and
dentin, and
root of root of
a tooth a tooth
with their with their associated
associated caries-free
caries-free and caries-
and caries-associated
associated microbiota.microbiotas
microbiota. Caries-free Caries-freecolonize
microbiotas colonize
the tooth surfacethe
as tooth
diversesurface as diverse
communities that
communities that respond to dietary carbohydrate challenge by producing acid, favoring enamel
respond to dietary carbohydrate challenge by producing acid, favoring enamel demineralization that
demineralization that is neutralized by microbiome community activity that includes the produc-
is neutralized by microbiome community activity that includes the production of ammonia deiminase
tion of ammonia deiminase and urease activity (remineralization). Enamel caries derives from the
and urease activity
acid-induced (remineralization).
enrichment Enamel species
of highly acidogenic caries derives from the acid-induced
and suppression enrichment
of acid-sensitive species,
of highly acidogenic species and suppression of acid-sensitive species, leading to a
leading to a reduction in community diversity. Caries in dentin, including root caries at the toothreduction in
community diversity. Caries in dentin, including root caries at the tooth surface, generally comprises
a more diverse microbiota than enamel caries with moderately rather than highly acidogenic species
owing to the reduced mineral content of dentin. Caries progression deep in dentin can involve acidic
demineralization in addition to increasing proteolytic activity, leading to higher pH values in deep
lesions. The sequence of caries progression shown is based on Takahashi and Nyvad [73]. Species
based on text references.
Microorganisms 2024, 12, 121 9 of 45
Pioneer streptococci species can dominate the supragingival regions of teeth and
appear to be uniquely attuned to the fluctuating conditions of the oral cavity due to their
advanced ability to regulate gene expression and protein production for attachment to
the dental pellicle [82]. For example, the regulatory mechanisms of S. gordonii allow it to
thrive under a certain set of environmental conditions [83]. Similar mechanisms in other
species help define which bacteria can co-inhabit the same oral niche [84]. Of the pioneer
species, S. gordonii is persistently adherent to the tooth enamel, given its high affinity
for proteins in the tooth pellicle. S. gordonii can utilize adhesion proteins (i.e., Has) and
amylase-binding protein A (AbpA) to mediate receptor–ligand attachments to teeth. The
Has adhesion receptors of S. gordonii can bind specifically to the terminal sialic acid of
host sialoglycoconjugates [80], whereas AbpA interacts directly with human α-amylase, a
salivary enzyme that is paramount for food breakdown [85]. Due to the covalent nature of
these interactions, S. gordonii was found to firmly attach to the tooth, comprising up to 70%
of the bacterial community in this early dynamic stability stage of plaque development [85].
3.2.3. Early Colonizers and the Acidogenic Stage of Plaque Biofilm Development
While pioneer species are the first to colonize the tooth pellicle, the appearance of early
colonizer microorganisms in succession parallels changes in the local plaque environment
that derive from the amassing pioneer species; such accumulation generates conditions
no longer favorable for survival of the pioneer species owing to oxygen and nutrient
Microorganisms 2024, 12, 121 10 of 45
deprivation as well as increased host sugar consumption [69]. The initial horizontal
coaggregation of bacteria over the tooth surface is followed by vertical coaggregation
away from the tooth surface [93], resulting in biofilm build up that selects for persistent
metabolically diverse species that favor growth at low pH. Co-adhesion between the
co-aggregating pioneer and early colonizers often occurs by uni- or bimodal protein lectin–
oligosaccharide receptor interactions, which allow for the development of a structured
biofilm architecture [94].
S. gordonii, S. sanguinis, and S. oralis, as non-mutans streptococci, are often considered
“accessory pathogens” because of their contributions to plaque architecture. Importantly,
their interactions are often species-specific, such that the attachment of an early colonizer is
entirely dependent on the preceding establishment of its partner pioneer colonizer. Thus,
the development of the caries biofilm is not so much a one-way, stepwise progression
as it is an amalgamation that is dependent on species-specific population dynamics that
essentially generate niches for the next stage of colonizers.
The early colonizers produce acidic byproducts from the fermentative metabolism
of dietary carbohydrates. A longer acidic challenge leads to suppression of more acid-
sensitive oral bacteria and an increase in acid-tolerant species. Biofilm acidity is associated
with demineralization of the enamel surface and weakening of the outer protective enamel
layer of the tooth. This leads to surface roughening, which can instigate the colonization
of more aggressive microbial pathogens [72,95]. This is the stage in which there can be an
acid rebalance of the bacterial community so that enamel remineralization and any clinical
signs of caries are reversed.
3.2.4. Secondary Colonizers and the Aciduric Stage of Plaque Biofilm Development
Next in the microbial succession are the secondary colonizers, which shift the mainly
streptococci, actinomyces, and veillonella microbiota to a more diverse constituency of
microorganisms capable of broader metabolism. This stage represents a more acidogenic
stage of the ecological plaque hypothesis [72,96]. Together, the secondary colonizers
S. mutans and Lactobacillus, Bifidobacterium, and Scardovia species contribute to climax
communities that define the environmental conditions of the oral cavity, and which can
enhance the pathogenic potential of the colonizers involved. If the enamel surface collapses,
there is cavity formation, which can progress to involve the underlying dentin.
These findings indicate that the microbiota of initial caries is consistent with the
ecological plaque hypothesis with regards to the sequence of colonization and inclusion
of highly acidogenic and acid-tolerant species, which include S. mutans and S. wiggsiae
(when assayed) and several other streptococci in the caries microbiome. Initial lesions
are clinically reversible, and many will not progress to cavities. Many of the white-spot-
lesion-associated microbiota, particularly the actinomyces, are moderately acidogenic and
acid-tolerant, consistent with the microbiome at the borderline of the dynamic stability
and acidogenic stages (Figure 2) of the expanded ecological plaque hypothesis. Following
the recent observation that S. mutans can be concentrated as “rotunds” over white-spot
lesions [125], it seems likely that S. mutans alone could be the prime species that drives
enamel demineralization. To evaluate how frequently this highly localized, species-specific
demineralization occurs in initial and more advanced caries, highly localized site sampling
of progressing lesions will be required. If found, it would suggest that S. mutans is a
keystone pathogen of caries.
cariogenesis [135]. The study authors concluded that some Actinomyces could be cariogenic,
considering their ability to survive in acidic environments and to ferment carbohydrates.
Microorganisms 2024, 12, 121 microbiome of carious dentin compared with crown/coronal tooth sites was observed from
16 of 47
metatranscriptome experiments where a more diverse microbiota was observed when gene
expression profiles were mapped back to species [142] (Figure 3). Moreover, species in the
dentin
ease, as had a wide
reported fromrange of metabolic
16S rRNA capabilities,
gene community reflecting
profiling differences
approaches in the ecology of
in S-ECC com-
pared with
dentin caries-free
caries comparedchildren
with[109].
that on the tooth surface.
Figure 3.3.Microbial
Figure Microbialspecies and taxa,
species including
and taxa, viruses, viruses,
including detected from gene expression
detected from geneprofiles in
expression profiles in
coronal and dentin caries. Bacterial samples were taken from coronal caries and caries-free sites
coronal and dentin caries. Bacterial samples were taken from coronal caries and caries-free
and dentin caries from early childhood caries in children with progressing lesions. Functional pro- sites and
dentin caries
filing was from early
performed childhood
on purified caries
bacterial RNAin children
using HUMAnN with2.0,
progressing
version 0.9.9lesions. Functional profiling
(HMP Unified
was performed on purified bacterial RNA using HUMAnN 2.0, version 0.9.9 (HMP Unified Metabolic
Analysis Network). Species mapped from gene expression profiles showed the greatest diversity from
dentin caries samples. Dentin caries n = 6; coronal caries n = 5; caries n = 4. * difference detection,
Chi-square > 0.05. Data from Kressirer et al. [142].
Microorganisms 2024, 12, 121 16 of 45
The widely divergent species and genotypes that colonize the oral cavity suggest
that the natural sources of Lactobacillus include exogenous and opportunistic colonizers
that reside outside of the human oral cavity, likely originating from food products or
other fermented materials [192]. For example, of the lactobacilli detected in caries, L. fer-
mentum and L. casei are among the species frequently detected in animals, plants, and
fermented
Figure
Figure foods,ofofconsistent
4.4.Diversity
Diversity with species.
oralLactobacillus
oral Lactobacillusaspecies.
dietary
(A) origin.
(A) L. gasseri,
Composition
Composition L. acidophilus,
of Lactobacillus
of Lactobacillus L.isolated
species
species vaginalis,
isolated L.
in
in the
crispatus,
the
oral oral
cavity and
cavity
of L. 5-year-old
3- of
to jensenii
3- are
to 5-year-old ordinary
children (N =colonizers
children (N (B)
74). = 74). of the
(B) healthy
Distribution
Distribution vagina (FigureLactobacillus
of twenty-one
of twenty-one Lactobacillus 6) species
and/or
species
identified identified
the gastrointestinal in with
in children children
tract. L.with
severe severe
salivarius
early early
and
childhood childhood
L.caries
rhamnosus caries
(S-ECC,are (S-ECC,
N =commonly
37) N used
= 37)without
and children as and children
probiotics
caries
without
to suppress
(CF, caries
N = 37). (CF, N = shows
pathogenic
The figure 37).intestinal
Thethat
figure shows that
thebacteria
abundance the
andandsoabundance and
are considered
distribution distribution
of thebeneficial of the Lactobacil-
organisms.
Lactobacillus species were
lus species were significantly different between the two groups of children [189].
significantly different between the two groups of children [189].
The relative
Taken importance
together, of individual
these observations Lactobacillus
suggest species
that a carious to could
lesion dentalrepresent
caries; their ori-
the pri-
gins, transmission and colonization pathways; their diversity, stability and roles
mary ecological niche for lactobacilli colonization, furthering the notion that the lactobacilli– in caries
ecology;
caries and theircould
relationship interactions with other [179,182,185,186].
be species-specific acid-sensitive or cariogenic bacterial species
needMostfurther investigation and clarification.
Lactobacillus species in carious lesions Clinically,
cohabitatethewith
presence
other of Lactobacillus
lactobacilli. in the
Multiple
oral cavity has been used as an indicator of fermentable carbohydrates
Lactobacillus species can promote caries progression in dentinal lesions. The reduction in and a caries-
inducing oral
Lactobacillus environment.
colonization onceCommercial
carious lesionschairside tests measuring
were successfully salivary
restored is dueLactobacillus
to the loss
counts based on selective isolation have been used in clinical studies
of Lactobacillus’ ecological niche in the cavities [186,187,190–194]. Taken together for caries risk as-
with
L.sessment
fermentum,andL.post-treatment
gasseri, L. casei,evaluations [193].
L. salivarius, Taken together,
L. rhamnosus, and L.this information
plantarum as theshould
most
help scientists and clinicians improve caries management.
Microorganisms 2024, 12, 121 21 of 45
frequently detected taxa in advanced dentin caries, these species could potentially be
classified as caries pathogens [187,195].
The widely divergent species and genotypes that colonize the oral cavity suggest that
the natural sources of Lactobacillus include exogenous and opportunistic colonizers that
reside outside of the human oral cavity, likely originating from food products or other
fermented materials [192]. For example, of the lactobacilli detected in caries, L. fermentum
and L. casei are among the species frequently detected in animals, plants, and fermented
foods, consistent with a dietary origin. L. gasseri, L. acidophilus, L. vaginalis, L. crispatus, and L.
Microorganisms 2024, 12, 121 jensenii are ordinary colonizers of the healthy vagina (Figure 6) and/or the gastrointestinal 22 of 47
tract. L. salivarius and L. rhamnosus are commonly used as probiotics to suppress pathogenic
intestinal bacteria and so are considered beneficial organisms.
100%
80%
% Subjects
60%
40%
20%
0%
Figure 6. Lactobacillus species detected in vaginal and gingival samples. Oral (gingival) and vaginal
Figure 6.were
samples Lactobacillus species
taken from detected in
194 pregnant vaginalinand
women the gingival samples.
first trimester Oral
[196]. (gingival)
Samples wereand vaginal
analyzed
samples
using DNAwere taken
gene fromin194
probes pregnant women
a checkerboard formatin with
the first
a 10trimester [196].
5 threshold Samples
of species were analyzed
detection. Of the
using DNA gene probes in a checkerboard format with a 105 threshold of species detection. Of the
Lactobacillus species assayed, most were detected in both sample sites, suggesting that the vagina
Lactobacillus species assayed, most were detected in both sample sites, suggesting that the vagina
could be a source of oral lactobacilli in infants. In contrast, other species typical of subgingival
could be a source of oral lactobacilli in infants. In contrast, other species typical of subgingival
sites, including Porphyromonas
sites, including and Prevotella
Porphyromonas and Prevotella species,
species, were
were detected
detected more
more frequently
frequently in
in the
the gingival
gingival
samples. * Difference detection, Chi-square >
samples. * Difference detection, Chi-square > 0.05. 0.05.
The relative importance of individual Lactobacillus species to dental caries; their origins,
5.3. Actinomycetaceae
transmission and colonization pathways; their diversity, stability and roles in caries ecology;
Actinomyces
and their and with
interactions related species
other have been
acid-sensitive recognizedbacterial
or cariogenic as members
speciesofneed
plaque bio-
further
films for many decades. Current taxonomy recognizes several families and
investigation and clarification. Clinically, the presence of Lactobacillus in the oral cavity genera in the
Actinobacteria class that, based on reports in the literature, are relevant
has been used as an indicator of fermentable carbohydrates and a caries-inducing oral to dental caries.
These includeCommercial
environment. species in the generatests
chairside Actinomyces,
measuring Rothia,
salivaryBifidobacterium, Parascardovia,
Lactobacillus counts based
Scardovia,
on Corynebacterium,
selective isolation have Olsenella,
been usedand Atopobium,
in clinical the taxonomy
studies of which
for caries risk can beand
assessment ac-
cessed via the eHOMD
post-treatment evaluations database,
[193]. version 3.1 (https://www.homd.org/taxa/tax_table).
Taken together, this information should help scientists
Only a few
and clinicians species,
improve however,
caries have been examined for cariogenic traits as opposed
management.
to overall disease association. Specifically, Actinomyces were cultured from plaque and
5.3. Actinomycetaceae
dentin samples associated with carious lesions in children [100] and A. viscosus was
identified as theand
Actinomyces dominant
related species in root
species have caries
been in adults
recognized as [126].
members While A. viscosus
of plaque can
biofilms
lower
for thedecades.
many pH belowCurrent
5 in glucose broth,recognizes
taxonomy it was not several
as acidogenic
families orand
acid-tolerant
genera in as
theS.Acti-
mu-
tans isolates
nobacteria at an
class initial
that, basedacidic pH [197].
on reports in theMoreover,
literature,in areexperimental animals,
relevant to dental A. israelii
caries. These
was found
include to beinassociated
species the generawith root caries,
Actinomyces, but not
Rothia, with coronalParascardovia,
Bifidobacterium, caries [198]. Taken col-
Scardovia,
Corynebacterium, Olsenella,
lectively, and despite and Atopobium,
the taxonomy the taxonomy
of Actinomyces beingofupdated
which can be accessed
several via the
times since the
eHOMD
1980s, thedatabase,
actinomyces version 3.1 (https://www.homd.org/taxa/tax_table).
continue to be consistently isolated from carious lesions.
The association of individual Actinomyces species with caries status supports species
specificity in health and disease. Strains of 24 different Actinomyces species were report-
ed as having a broad-based ability to lower pH when grown under neutral (pH7) and
acidic (pH5.5) conditions [114]. When grown in glucose broth, some Actinomyces species,
including Actinomyces johnsonii, Actinomyces graevenitzii, and several unnamed species,
Microorganisms 2024, 12, 121 22 of 45
Only a few species, however, have been examined for cariogenic traits as opposed to
overall disease association. Specifically, Actinomyces were cultured from plaque and dentin
samples associated with carious lesions in children [100] and A. viscosus was identified
as the dominant species in root caries in adults [126]. While A. viscosus can lower the pH
below 5 in glucose broth, it was not as acidogenic or acid-tolerant as S. mutans isolates at
an initial acidic pH [197]. Moreover, in experimental animals, A. israelii was found to be
associated with root caries, but not with coronal caries [198]. Taken collectively, and despite
the taxonomy of Actinomyces being updated several times since the 1980s, the actinomyces
continue to be consistently isolated from carious lesions.
The association of individual Actinomyces species with caries status supports species
specificity in health and disease. Strains of 24 different Actinomyces species were reported
as having a broad-based ability to lower pH when grown under neutral (pH7) and acidic
(pH5.5) conditions [114]. When grown in glucose broth, some Actinomyces species, including
Actinomyces johnsonii, Actinomyces graevenitzii, and several unnamed species, were capable
of lowering pH < 4 and were nearly as acid-tolerant as S. mutans and S. sobrinus, consistent
with the characteristics of known cariogenic bacteria. Other Actinomyces species, including
Actinomyces massiliensis, Actinomyces georgiae, and Actinomyces meyeri, were less acidogenic,
reaching final pH values close to pH 5, which is like the acidogenic potential of species
known to reside in caries-free sites. Thus, these differences in acidogenic and acid-tolerant
properties for Actinomyces species support the specificity of Actinomyces in both health and
disease and that a lack of species differentiation will obscure caries associations.
Bifidobacteria have been associated with dental caries since the early 1900s, including
in a study of childhood caries in 1917 [58]. Bifidobacteria isolated from root caries were
highly acidogenic [127], although cariogenicity testing in experimental animals failed to
show significant caries induction, which was attributed to poor colonization in the animals
tested [199,200]. The current taxonomy of the bifidobacterial group recognizes several
species that colonize the oral cavity, including species in the genera Scardovia, Parascardovia,
and Alloscardovia [113,201]. S. wiggsiae was significantly associated with S-ECC in young
children based on molecular analysis of the oral clone CX010 [106] and an anerobic culture
study [113]. A selective medium was used to isolate several Bifidobacterium species from
occlusal lesions in both children and adults, including B. dentium, P. denticolens, Scardovia
inopinata, S. wiggsiae (Scardovia genosp. C1), and Bifidobacterium longum [201]. The results
of selective isolation experiments also revealed a strong association of bifidobacteria with
increasing root caries severity [130].
Bifidobacterium species have been associated with clinical models of disease progression.
Scardovia inopinata was associated with the demineralization of enamel and dentin sections
worn in oral appliances [155]. White-spot initial carious lesions in adolescents with fixed
orthodontic appliances were associated with S. wiggsiae in cross-sectional studies [122]
and with S. wiggsiae and B. dentium in longitudinal monitoring [123]. Further, higher
proportions of bifidobacteria were isolated from caries-active than caries-free children [202].
These findings implicate Bifidobacterium species as playing a larger role in more advanced
carious lesions than in early lesions. Furthermore, higher proportions of children with
advanced caries had Bifidobacterium species and S. wiggsiae in saliva compared with initial
caries and caries-free children [49]. Comparison of bacteria from a metatranscriptomic
analysis of dentin caries detected higher levels of S. wiggsiae and B. dentium compared with
coronal caries and caries-free children [142] (Figure 3).
Clinical and in vitro studies support a symbiotic relationship between Scardovia and
bifidobacteria with S. mutans. For instance, in children’s saliva samples, there was a positive
association between S. wiggsiae and S. mutans [49]. Analysis of adolescents with lower and
higher levels of S. mutans revealed an association of S. wiggsiae with S. mutans in association
with more aggressive caries [154]. Bifidobacterium species did not form biofilms as a single
species when inoculated onto glass slides [203]. This lack of biofilm growth may in part
explain why it was difficult to implant bifidobacterial [199] or S. wiggsiae [200] in animal
models for cariogenicity testing. In vitro biofilms did, however, form when strains were
Microorganisms 2024, 12, 121 23 of 45
co-infected with S. mutans [203], and, for P. denticolens and Scardovia inopinata, lower pH
values were achieved in dual-species culture than when either species was cultured alone.
In other in vitro assays, S. wiggsiae strains were found to be as acidogenic and acid-tolerant
as S. mutans [114].
These findings reflect a resurgence in interest in Actinobacteria, especially in Scardovia-
related species. Findings from dual-species analysis indicate the importance of considering
the action of the whole microbial community rather than relying on the activity of individual
species to fully understand their cariogenic potential.
with active caries compared with two healthy individuals [213]. Analysis of the metabolic
potential of the caries metagenome showed that samples from diseased individuals tended
to cluster together, suggesting similar sets of functions were present in their metagenomes.
Interestingly, the oral microbiomes from healthy subjects included significantly enriched
genes involved in the biosynthesis of antibacterial peptides, such as bacteriocins; periplas-
mic stress-response genes like degS and degQ; capsular and extracellular polysaccharides;
and bacitracin stress-response genes; while samples from caries-active subjects had a high
frequency of genes involved in functions such as iron scavenging and oxidative and osmotic
stress response.
The results of these metagenomic studies suggest that specific metabolic genes and
pathways are associated with oral diseases, although more in-depth and functionally
informative analyses are required to confirm these conclusions. Some of these genes may
have the potential to become diagnostic markers.
6.2. Metatranscriptome
Although a metagenomic approach can reveal the total genetic potential of a microbial
community, it cannot elucidate which genes are being actively expressed in real time. The
human oral microbiome exists in a continuously changing environment where pH, organic
carbon, and oxygen levels fluctuate on a hundred-fold or even a thousand-fold scale within
minutes [214,215]. All of these dynamic environmental changes can have varying impacts
on the metabolic activity of different bacterial species in the community and so affect the
genes that are actively expressed by that community. Thus, detecting and analyzing the
gene transcripts of a microbial community offers real-time information that can help detect
the metabolically active microbial members and identify the genes expressed under a given
set of conditions.
Metatranscriptomic analysis characterizes the gene expression profiles of entire mi-
crobial communities based on the sets of transcripts that are synthesized under diverse
environmental conditions. Instead of addressing the question “what are oral microbes
capable of doing?”, as in metagenomics, metatranscriptomics offers answers to “what are
oral microbes actually doing?” [216,217].
Using a metatranscriptomic approach, Simon-Soro et al. identified the RNA-based,
metabolically active bacterial compositions of carious lesions at different stages of disease
progression in an effort to provide a list of potential etiologic agents for tooth decay [218].
They demonstrated that the microbiota associated with dental caries in adults is highly
complex, with each sample containing between 70 and 400 metabolically active species.
The compositions of these bacterial consortia varied among individuals and between caries
lesions in the same individuals. Enamel and dentin lesions also had a different makeup
of metabolically active microbes. In sum, their data confirmed that the etiology of dental
caries is likely tissue-dependent and that the disease has a clear polymicrobial origin. The
relatively low proportion of S. mutans detected in the caries sites examined indicated that
this bacterial species can be present as a minority, leading the authors to question the
importance of S. mutans as the main etiological agent in dental caries. Alternatively, these
observations implicate S. mutans as a keystone pathogen that, despite its low abundance
at the caries site, could remodel the caries microbiota to favor dysbiosis [219] and form
concentrations of S. mutans above localized sites of demineralized enamel [125].
A study of the metatranscriptome of progressing early childhood caries lesions, how-
ever, indicated a clear positive association of genes mapping to S. mutans from coronal
(enamel) and dentin lesions compared with caries-free children [142] (Figure 3). While
there was considerable variability in microbial gene expression within the clinical groups,
similar to that observed in adults [218], total enzyme expression was higher in dentin caries
compared with coronal caries and caries-free samples [142]. Further, there was greater
diversity in the operational taxonomic units (OTUs) that genes from dentin mapped to
than in those from coronal caries, although sample sizes were smaller from dentin than
from coronal sites. Functional profiling revealed higher levels of alcohol dehydrogenase
Microorganisms 2024, 12, 121 25 of 45
from Neisseria sicca and choline kinase from several non-mutans streptococci in caries-free
samples; hence, both taxa are associated with healthy plaque. The expressed sequences
in coronal (enamel) caries from S. mutans were mainly derived from DNA ligase genes,
suggesting increased metabolic activity in that species. A wider range of gene expression
activity was observed in dentin than in coronal caries, including expression of uracil DNA
glycosylase from S. wiggsiae and urease from A. naeslundii. Moreover, the higher levels of
gene expression patterns mapping to S. wiggsiae in dentin caries compared with coronal
caries, suggest S. wiggsiae could be a major player in caries progression in dentin. Overall,
metatranscriptomic analysis revealed some differences in the enzyme/metabolic activities
that were expressed in microbiomes associated with dentin caries, coronal caries, and
caries-free samples, respectively [142].
Metatranscriptomic studies thus revealed marked differences in bacterial composition
and metabolism between coronal and dentin caries, suggesting that the microbial commu-
nities in enamel lesions exhibited different functions than those of more advanced, dentin
cavities, where bacteria appear to be specialized in utilizing sugars associated with dentin
tissue and degrading proteins. These data support the hypothesis that dental caries is
not a single disease but a tissue-dependent process with different etiologies, as discussed
above [99] and consistent with the ecological hypothesis for dentin caries proposed by
Takahashi and Nyvad [73].
Using RNA-seq to perform global gene expression analysis of the dental plaque micro-
biota derived from 19 twin pairs that were either concordant (caries-active or caries-free) or
discordant for dental caries [220] revealed similarities in gene expression patterns. Thus,
this twin-pair study allowed an assessment of the relative contributions of human genet-
ics, environmental factors, and caries phenotype on the microbiota’s transcriptome. The
results revealed transcripts encoding functions related to monosaccharide and disaccha-
ride metabolism, accounting for a significant portion of the dental biofilm transcriptome
(around 15% of the total) [220]. Transcripts encoding functions associated with disaccharide
metabolism were more prevalent than those associated with monosaccharide metabolism
by a factor of two. Interestingly, transcripts encoding functions related to antibiotic resis-
tance and tolerance of toxic compounds were also expressed in the oral biofilm, while genes
involved in bacteriocin expression and acid stress represented only a small fraction of all
transcripts across all individuals. Furthermore, correlation analysis of transcription identi-
fied several functional networks, suggesting that inter-personal environmental variables
may co-select for groups of genera and species [220].
By applying a novel computational framework (metaModules) for the automated
identification of key functional differences between health and disease-associated commu-
nities, May et al. [221] were able to identify key functional subnetworks that are relevant
to dental caries, as noted in the metatranscriptomic data obtained by Peterson et al. [220].
Their results showed that the health-associated KEGG Orthology groups (Kos) were mainly
constituents of the pathways associated with amino acid biosynthesis and pyrimidine,
purine, and pyruvate metabolism, as well as glycerophospholipid metabolism. The caries-
associated subnetwork included nine Kos from the pathways of the phosphotransferase
system and fructose/mannose metabolism, supporting the notion that microbial carbohy-
drate acquisition and catabolism are important in dental caries etiology [96].
In sum, metatranscriptomic analysis allows one to gain insight into the genes that are
actively expressed in complex bacterial communities, enabling the elucidation of dynamic
functional changes that govern the microbiome’s functions in given contexts, its interactions
with the host, and the functional alterations that accompany the transition of a healthy
microbiome into a dysbiotic one.
6.3. Multi-Omics
With the advancement of sequencing technologies, protein and small-molecule anal-
yses, and the development of new bioinformatics tools, studies of host-associated micro-
biomes, including the caries microbiome, have entered a new era. Investigators are now
Microorganisms 2024, 12, 121 26 of 45
significant contributing factor to the remarkable decline in tooth decay in the decades since
it was introduced. Community-based fluoridation in drinking water (≥0.7 parts per million
F) represents a significant public health achievement of the 20th century for its efficacy in
preventing dental caries [12] that has been consistently supported by scientific evidence
worldwide. A study report of 2018 estimated that the preventive fraction for US children
and adolescents was 30% (95% CI 11–48%) for primary teeth and 12% (95% CI 1%, 23%)
for permanent teeth [239]. This cost-effective community-based approach is dependent
on access to drinking water systems and public health policies at national, state, or local
governmental levels [240]. Use of toothpastes or mouthrinses containing sodium fluoride
(NaF), amine fluoride (AmF), acidulated phosphate fluoride (APF), and stannous fluoride
(SnF2 ), among others, reduces plaque accumulation on tooth surfaces [241] and lowers the
cariogenicity of dental plaque [242]. Two mechanisms described as underlying fluoride
anticaries activity—antimicrobial action and promoting enamel hardness via chemical
reaction—will be described in the following two subsections.
Figure 7. Acid production from a glucose solution with added fluoride on in vitro dental biofilms.
Figure 7. Acid production from a glucose solution with added fluoride on in vitro dental bio-
Effects of a glucose
films. Effects solutionsolution
of a glucose with added
withfluoride on the inon
added fluoride vitro
thepH of dental
in vitro biofilms.
pH of dental pH dropped
biofilms. pH
in 10-day in
dropped biofilms
10-dayafter an overlay
biofilms after anofoverlay
glucoseoforglucose
glucoseor+ glucose
10 ppm +fluoride
10 ppm[247].
fluoride [247].
Silver diamine
Clinically, fluoride
long-term (SDF) tototreat
exposure cariesreduced
fluoride is basedthe
on the activity
salivary of both
levels silver
of mutans
and fluoride. For centuries, elemental silver (Ag) has been known to exhibit antimicrobial
streptococci, lowered caries scores among school children [249,250], and prevented
effects due to its properties as a heavy metal. Silver was the basis of “Howe’s solution”,
used to treat rampant caries in children 100 years ago. The antimicrobial effect of silver
compounds was established for the prevention and treatment of infections in medicine [265].
In dentistry, SDF’s caries-arrest effect was demonstrated in the late 1960s and early 1970s in
Japan. Application of topical SDF, while causing black staining on treated tooth surfaces,
was effective in arresting caries progression in 66% to 75% of primary teeth [266,267], 41%
to 65% of first permanent molars [268,269], and 18% to 71% of root caries in elders [270].
Antimicrobial mechanisms for caries suppression by SDF include, at the cellular
level, interference with bacterial amino and nucleic acid formation, alteration of cell-wall
synthesis and cell division, and disabling of metabolic and reproductive functions, leading
to inhibition of bacterial growth and biofilm formation [271]. An antibacterial effect of SDF
against S. mutans growth with inhibition of dextran-induced agglutination was reported
in the 1970s [272]. Subsequent studies showed that a 3.8% SDF solution could effectively
suppress Enterococcus faecalis biofilm formation [273], which could be valuable for treating
root canal infections. Knight et al. conducted a series of experiments demonstrating that
application of SDF reduced S. mutans viability and inhibited biofilm formation, reducing
the bacteria-induced demineralization of dentin and caries progression [274,275]. Chu and
Mei et al. reported the antimicrobial effect of a 38% SDF solution against multi-species
cariogenic complexes (S. mutans, S. sobrinus, L. acidophilus, L. rhamnosus, and Actinomyces
naeslundii) on dentin carious lesions [276,277]. A formulation of SDF with potassium iodide
(SDF/KI) reduced S. mutans colonization in dentinal tubules compared with chlorhexidine
or other chemo-mechanical products [278]. Furthermore, SDF suppressed S. mutans biofilm
formation on dentin caries models with a superior antibacterial effect against S. mutans
compared with NaF and with SDF + NaF (Figure 8) [279].
zation of the enamel and dentin [286]. In addition to the formation of an impermeable
layer of silver phosphate, calcium fluoride, and fluorohydroxyapatite in SDF-treated car-
ious lesions, highly concentrated silver precipitation zones form around the carious le-
sions, thereby blocking dentin tubules, which could contribute to the physiochemical
Microorganisms 2024, 12, 121 role of silver compounds in caries arrest. 29 of 45
Figure 8. Effects of sodium diamine fluoride (SDF) on S. mutans biofilms cultured on dentin blocks
Figure 8. Effects
in vitro. Shownof sodium diamine
are scanning fluoride
electron (SDF) on S.
micrographs mutans
(SEM, leftbiofilms cultured
panels) of on dentin
the biofilm blocks and
topography
in vitro. Shown are scanning electron micrographs (SEM, left panels) of the biofilm topography
the images from confocal laser scanning microscopy (CSLM, right panels) of the S. mutans biofilm on
dentin caries lesions treated with (a) 38% SDF solution plus 5% NaF varnish; (b) 38% SDF solution
alone; (c) 5% NaF; and (d) a water-treatment control. The green color represents live bacterial cells;
the red color represents dead bacterial cells (magnification ×1000). The green intensity represents the
amount of biofilm formed in the carious lesions. Modified based on Yu et al. 2018 [279].
centrated silver precipitation zones form around the carious lesions, thereby blocking
dentin tubules, which could contribute to the physiochemical role of silver compounds in
caries arrest.
Overall, topical applications of fluoride have proven to be an effective anti-caries
measure. A review of data from 71 students concluded that the use of fluoride toothpastes
resulted in a 23% to 36% caries reduction depending on the fluoride concentration when
compared with placebo formulations [281]. The use of fluoride mouthrinses in 37 random-
ized controlled trials of over 15,000 children and adolescents resulted in a 27% reduction
in caries increment for permanent tooth surfaces when compared with placebo or no
treatment [250]. Hence, fluoride-containing toothpastes and mouth rinses are effective in
school-based programs for caries prevention in children, particularly in countries with a
high prevalence of caries and limited dental care resources. SDF treatment is minimally
invasive, inexpensive, and time-saving in application. Therefore, it has been considered
as an alternative treatment for at-risk patients when other forms of caries control are not
available or not appropriate [287,288]. Nevertheless, there are limitations in anti-caries
effectiveness for fluoride-containing mouthwashes, FV, and SDF, suggesting that improved
treatment and prevention approaches are needed for dental caries.
Historically and contemporarily, there have been several endeavors to combat dental
caries by precisely targeting S. mutans, although none have maintained substantial traction
long-term. Research investigating the feasibility of active or passive immunization against
dental caries has been sporadic. Early investigations on the topic have been excellently
reviewed [296]. More recent studies have explored vaccination using a recombinant P1
adhesin antigen [297], a DNA-based vaccine against glucosyl-transferases and surface pro-
teins [298], and a glycoconjugate vaccine based on rhamnan surface polysaccharides [299].
Unfortunately, past, present, and likely future translational efforts to move anti-caries
vaccine research into clinical trials face significant headwinds because caries, by itself, is
not a life-threatening disease. There are currently no licensed vaccines to prevent dental
caries, and, to our knowledge, only one candidate vaccine has proceeded to phase II clinical
trials [300]. Conceptually, the use of bacteriophages is an attractive approach to combat
S. mutans and dental caries, but this has received relatively little attention. Although the
few phages known to infect S. mutans were lytic and completely eliminated viable counts
from single-species biofilms, the phages demonstrated a highly stringent host specificity,
which was considered a significant disadvantage, particularly considering the high intra-
species diversity exhibited by S. mutans [reviewed in [301]]. No testing in multi-species
communities or further studies has been reported.
Probiotics approaches have sought to displace wild-type S. mutans using S. mutans
strains engineered for reduced pathogenesis or species which either compete with, or
directly antagonize, S. mutans [reviewed in [302,303]]. Although more recently discovered
species, such as Streptococcus dentisani [304] and Streptococcus A12 [90], hold promise com-
pared with older candidates, no probiotic formulations have successfully demonstrated
safety and efficacy in adequately rigorous clinical trials [305,306]. Two small molecules
were recently reported to exhibit the ability to specifically disperse or inhibit S. mutans
biofilms [307,308]. However, disruption of S. mutans biofilm alone, with minimal effect on
the overall dental plaque ecology, is likely to allow rapid reestablishment of the problematic
community and require constant application of the therapy. Recent work has identified
two antimicrobial peptides, ZXR-2 [309] and CLP-4 [310], and a vitamin D derivative, doxer-
calciferol [311], with antimicrobial activities against S. mutans. However, the antimicrobial
specificity of these molecules against S. mutans was not reported in these studies.
Specifically targeted antimicrobial peptides (STAMPs) were developed to address
the need for precision antibiotic therapy. STAMPs are synthetic peptides consisting of a
targeting domain to invoke specificity and a killing domain to exert antimicrobial action
against the intended species [312]. To design a STAMP directed/targeted to S. mutans, a
“G2” killing domain, consisting of a 16-residue segment of the well-characterized potent
broad-spectrum antimicrobial peptide novispirin G10, was chosen [313]. The targeting
domain selected was “C16”, which consisted of the 16 C-terminal residues of the S. mutans
pheromone, a competence-stimulating peptide (CSP). The directed/targeted and killing
moieties of C16G2 were joined by a flexible triglycine linker.
Analyses of C16G2 showed that it was capable of the targeted killing of S. mutans
in either planktonic or biofilm settings and that it could selectively kill S. mutans in a
three-species biofilm [313,314] as well as an in vitro, saliva-derived oral community, which
consisted of over 100 species [315]. This process was accompanied by a significant increase
in the relative abundance of Streptococcus mitis and other Streptococcus species associated
with good dental health [315]. Further work determined that C16G2 exerted its killing
effect through membrane disruption and that the cytotoxic effect of C16G2 was due to rapid
killing of S. mutans in less than one minute of exposure, acceptably swift for application as
an oral care product [316]. This STAMP was also soluble in aqueous solutions for delivery
into the oral cavity in a rinse formulation. A pilot clinical trial showed that, compared with
placebo, C16G2 significantly reduced the number of viable S. mutans in both plaque and
saliva samples, decreased lactic acid production, and increased the resting pH of dental
plaque [314]. Taken together, these results suggest that C16G2 is effective at selectively
suppressing S. mutans from the dental plaque milieu and remodeling the community to one
Microorganisms 2024, 12, 121 32 of 45
which is dominated by species that are associated with health. C16G2 is being developed
into a dental product by a biotechnology company (C3J Therapeutics, Inc., Marina del Rey,
CA, USA) and is currently in phase II clinical trials.
Several pH-responsive and acid-activated antimicrobial/anti-biofilm approaches have
been developed to focus on acid-generating bacteria and cariogenic biofilms. Quaternary
pyridinium salt (QPS) was developed by Sun’s group at the American Dental Association
Foundation [317]. Preliminary analysis showed that QPS exhibits pH-controlled antimicro-
bial activity that selectively inhibits the growth of acid-producing bacteria within a multi-
species community. Horev et al. reported pH-activated nanoparticles for controlled topical
delivery of farnesol to disrupt cariogenic biofilms [318]. In this approach, nanoparticles
are formed from diblock copolymers composed of 2-(dimethylamino) ethyl methacrylate
(DMAEMA), butyl methacrylate (BMA), and 2-propylacrylic acid (PAA) (p(DMAEMA)-b-
p(DMAEMA-co-BMA-co-PAA)) that self-assemble into cationic nanoparticles. Due to its
hydrophobic core, nanoparticles could effectively carry farnesol, a hydrophobic antimicro-
bial. The destabilization of nanoparticle cores under acidic pH will trigger the release of
farnesol, thus achieving the killing of cariogenic bacteria. Furthermore, farnesol-loaded
nanoparticles effectively attenuated biofilm virulence in vivo, resulting in a reduced num-
ber and severity of carious lesions using a clinically relevant topical regimen (2×/day) in a
rodent dental caries model.
Similarly, a strategy to control cariogenic biofilms using catalytic nanoparticles (CAT-
NP) was developed by Koo’s team at the University of Pennsylvania [319]. CAT-NP, with
peroxidase-like activity, is pH-responsive and can rapidly catalyze low concentrations of
H2 O2 at an acidic pH to produce free radicals to achieve simultaneous degradation of
the biofilm matrix as well as the killing of matrix-enclosed bacteria. Using 1 min topical
daily treatments, applicable for a clinical setting, they showed that CAT-NP in combination
with H2 O2 effectively suppressed caries development in a rat model. In a recent study, the
same group demonstrated the potential antimicrobial specificity of ferumoxytol iron oxide
nanoparticles (FerIONP) against biofilms harboring S. mutans through preferential binding
that promotes bacterial killing via in situ free-radical generation [320]. While further testing
is needed, these approaches hold the promise of being developed into oral therapeutics
that, instead of targeting one specific pathogen, can achieve the targeted control of a
group of bacteria displaying similar physiological properties that are relevant to disease
pathogenesis, e.g., the acid production and biofilm formation of cariogenic pathogens.
While the targeted approaches discussed above have yet to bear fruit in the form of an
approved therapeutic to prevent dental caries, the studies have contributed substantially to
our understanding of the disease and S. mutans and are foundational in guiding current and
future research. Dental caries remains a serious public health concern and one that could
strongly benefit from a precision therapy, such as STAMPs, for targeting a specific pathogen,
or pH-responsive, acid-activated antimicrobials for controlling a group of acid-producing,
cariogenic, biofilm-forming bacteria, to supplement current recommended fluoride and
hygienic regimens.
8. Conclusions
We conclude that while dental caries remains an important clinical problem world-
wide, our understanding of the associated microbial biofilms has greatly advanced. The
microbiology of dental caries was built on the concepts of the golden age of microbiol-
ogy, using the one-bacterium-for-one disease hypothesis. In caries research, studies of
cariogenic pathogens have focused mainly on S. mutans and lactobacilli. Cultural, and
especially molecular, approaches in microbiological analyses have evolved with associated
conceptual changes to focus on the biofilm community rather than individual species.
Health is now recognized as being associated with a balanced symbiotic community, includ-
ing acid-balancing microbial strategies, which is lost in the unbalanced dysbiotic change
associated with disease. The caries-associated microbiome is not characterized by a single
microbiota but varies between individuals, tooth locations, and rates of disease progres-
sion, with some evidence that the most aggressive caries is associated with the highly
acidogenic, acid-tolerant S. mutans and Scardovia species. Functional characterization of the
caries-associated microbiome can lead to a better understanding of microbial activities at a
community level. The study of the molecular function of the oral microbiome is leading
to an expanding characterization of caries as it relates to community activity. Prevention
and treatment approaches for caries have moved away from suppressing the whole com-
munity with antimicrobials, fluoride, and silver-containing agents, which had limitations
despite many treatment successes. Modern therapeutic approaches focus on targeting the
pathogenic components of the microbiome, including acidogenic species such as S. mutans,
to achieve ecological rebalancing of the dysbiotic community. We look forward to an
ever-increasing understanding of dental caries and strategies for its treatment, prevention,
and final eradication.
Author Contributions: This review was planned and written jointly by all authors. All authors have
read and agreed to the published version of the manuscript.
Funding: We acknowledge support from the following sources: Grace Spatafora: NIH-NIDCR
R01 DE014711; Yihong Li: NIH-NIDCR R01 DE019455; Xuesong He: NIH-NIDCR R01 DE023810,
NIH-NIDCR R01 DE030943, NIH-NIDCR R01 DE029479; Anne Tanner: William Bingham II Trust.
Data Availability Statement: Data are from literature sources as cited in the manuscript.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Milgrom, P. Tooth decay in our poorest children: What can we do? J. Indiana Dent. Assoc. 2000, 79, 24–26. [PubMed]
2. Pitts, N.B.; Zero, D.T.; Marsh, P.D.; Ekstrand, K.; Weintraub, J.A.; Ramos-Gomez, F.; Tagami, J.; Twetman, S.; Tsakos, G.; Ismail, A.
Dental caries. Nat. Rev. Dis. Primers 2017, 3, 17030. [CrossRef] [PubMed]
3. Meier, T.; Deumelandt, P.; Christen, O.; Stangl, G.I.; Riedel, K.; Langer, M. Global burden of sugar-related dental diseases in 168
countries and corresponding health care costs. J. Dent. Res. 2017, 96, 845–854. [CrossRef] [PubMed]
Microorganisms 2024, 12, 121 34 of 45
4. GBD 2017 Oral Disorders Collaborators; Bernabe, E.; Marcenes, W.; Hernandez, C.R.; Bailey, J.; Abreu, L.G.; Alipour, V.; Amini, S.;
Arabloo, J.; Arefi, Z.; et al. Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: A
systematic analysis for the global burden of disease 2017 study. J. Dent. Res. 2020, 99, 362–373. [CrossRef] [PubMed]
5. Agency for Healthcare Research and Quality. MEPS HC-188B: 2016 Dental Visits; Agency for Healthcare Research and Quality:
Rockville, MD, USA, 2018.
6. Fantom, N.; Serajuddin, U. The World Bank’s Classification of Countries by Income; Policy Research Working Paper 7528; The World
Bank: Washington, DC, USA, 2016.
7. Hescot, P. The new definition of oral health and relationship between oral health and quality of life. Chin. J. Dent. Res. 2017, 20,
189–192. [CrossRef]
8. Kassebaum, N.J.; Smith, A.G.C.; Bernabe, E.; Fleming, T.D.; Reynolds, A.E.; Vos, T.; Murray, C.J.L.; Marcenes, W.; GBD Oral
Health Collaborators. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions
for 195 countries, 1990–2015: A systematic analysis for the global burden of diseases, injuries, and risk factors. J. Dent. Res. 2017,
96, 380–387. [CrossRef]
9. Centers for Disease Control and Prevention. Oral Health Surveillance Report: Trends in Dental Caries and Sealants, Tooth Retention,
and Edentulism, United States, 1999–2004 to 2011–2016; Centers for Disease Control and Prevention, US Dept of Health and Human
Services: Atlanta, GA, USA, 2019.
10. Frencken, J.E.; Sharma, P.; Stenhouse, L.; Green, D.; Laverty, D.; Dietrich, T. Global epidemiology of dental caries and severe
periodontitis—A comprehensive review. J. Clin. Periodontol. 2017, 44 (Suppl. S18), S94–S105. [CrossRef]
11. FDI World Dental Federation. The Challenge of Oral Disease—A Call for Global Action. The Oral Health Atlas, 2nd ed.; Benzian, H.,
Williams, D., Eds.; FDI World Dental Federation: Geneva, Switzerland, 2015; pp. 16–21.
12. U.S. Department of Health & Human Services. Ten great public health achievements–United States, 1900–1999. MMWR Morb.
Mortal. Wkly. Rep. 1999, 48, 241–243.
13. Kim, H.N.; Kong, W.S.; Lee, J.H.; Kim, J.B. Reduction of dental caries among children and adolescents from a 15-year community
water fluoridation program in a township area, Korea. Int. J. Environ. Res. Public Health 2019, 16, 1306. [CrossRef]
14. Schluter, P.J.; Hobbs, M.; Atkins, H.; Mattingley, B.; Lee, M. Association between community water fluoridation and severe dental
caries experience in 4-year-old New Zealand children. JAMA Pediatr. 2020, 174, 969–976. [CrossRef]
15. Foley, M.A.; Sexton, C.; Spencer, A.J.; Lalloo, R.; Do, L.G. Water fluoridation, dental caries and parental ratings of child oral health.
Community Dent. Oral Epidemiol. 2021, 50, 493–499. [CrossRef] [PubMed]
16. Davies, G.M.; Neville, J.; Jones, K.; White, S. Why are caries levels reducing in five-year-olds in England? Br. Dent. J. 2017, 223,
515–519. [CrossRef] [PubMed]
17. Arheiam, A.A.; Harris, R.V.; Baker, S.R. Changes in dental caries and sugar intake before and during the conflict in Libya: A
natural experiment. Community Dent. Oral Epidemiol. 2020, 48, 201–207. [CrossRef] [PubMed]
18. Lin, M.; Thornton-Evans, G.; Griffin, S.O.; Wei, L.; Junger, M.; Espinoza, L. Increased dental use may affect changes in treated and
untreated dental caries in young children. JDR Clin. Trans. Res. 2019, 4, 49–57. [CrossRef] [PubMed]
19. Dye, B.A.; Mitnik, G.L.; Iafolla, T.J.; Vargas, C.M. Trends in dental caries in children and adolescents according to poverty status
in the United States from 1999 through 2004 and from 2011 through 2014. J. Am. Dent. Assoc. 2017, 148, 550–565. [CrossRef]
[PubMed]
20. Dye, B.A.; Tan, S.; Smith, V.; Lewis, B.G.; Barker, L.K.; Thornton-Evans, G.; Eke, P.I.; Beltran-Aguilar, E.D.; Horowitz, A.M.; Li,
C.H. Trends in Oral Health Status: United States, 1988–1994 and 1999–2004; Vital and Health Statistics; National Center for Health
Statistics: Atlanta, GA, USA, 2007; Volume 11.
21. Dye, B.A.; Thornton-Evans, G.; Li, X.; Iafolla, T. Dental Caries and Tooth Loss in Adults in the United States, 2011–2012; NCHS Data
Brief; US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health
Statistics: Hyattsville, MA, USA, 2015; pp. 1–8.
22. Lagerweij, M.D.; van Loveren, C. Declining caries trends: Are we satisfied? Curr. Oral Health Rep. 2015, 2, 212–217. [CrossRef]
23. World Health Organization. Global Oral Health Status Report: Towards Universal Health Coverage for Oral Health by 2030; World
Health Organization: Geneva, Switzerland, 2022.
24. Bernabe, E.; Sheiham, A. Age, period and cohort trends in caries of permanent teeth in four developed countries. Am. J. Public
Health 2014, 104, 115–121. [CrossRef]
25. Petersen, P.E.; Ogawa, H. Promoting oral health and quality of life of older people—The need for public health action. Oral Health
Prev. Dent. 2018, 16, 113–124. [CrossRef]
26. Fleming, E.; Afful, J. Prevalence of Total and Untreated Dental Caries among Youth: United States, 2015–2016; NCHS Data Brief; US
Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics:
Hyattsville, MA, USA, 2018; pp. 1–8.
27. Gupta, N.; Vujicic, M.; Yarbrough, C.; Harrison, B. Disparities in untreated caries among children and adults in the U.S., 2011–2014.
BMC Oral Health 2018, 18, 30. [CrossRef]
28. Peres, M.A.; Ju, X.; Mittinty, M.; Spencer, A.J.; Do, L.G. Modifiable factors explain socioeconomic inequalities in children’s dental
caries. J. Dent. Res. 2019, 98, 1211–1218. [CrossRef]
29. Jenson, L.; Budenz, A.W.; Featherstone, J.D.; Ramos-Gomez, F.J.; Spolsky, V.W.; Young, D.A. Clinical protocols for caries
management by risk assessment. J. Calif. Dent. Assoc. 2007, 35, 714–723. [CrossRef] [PubMed]
Microorganisms 2024, 12, 121 35 of 45
30. Bratthall, D.; Hansel Petersson, G. Cariogram—A multifactorial risk assessment model for a multifactorial disease. Community
Dent. Oral Epidemiol. 2005, 33, 256–264. [CrossRef] [PubMed]
31. World Health Organization. Oral Health Surveys: Basic Methods, 5th ed.; World Health Organization: Geneva, Switzerland, 2013;
pp. 42–47.
32. Frazao, P. Epidemiology of dental caries: When structure and context matter. Braz. Oral Res. 2012, 26 (Suppl. S1), 108–114.
[CrossRef] [PubMed]
33. Kutsch, V.K. Dental caries: An updated medical model of risk assessment. J. Prosthet. Dent. 2014, 111, 280–285. [CrossRef]
[PubMed]
34. Pitts, N. “ICDAS”—An international system for caries detection and assessment being developed to facilitate caries epidemiology,
research and appropriate clinical management. Community Dent. Health 2004, 21, 193–198.
35. Ismail, A.I.; Sohn, W.; Tellez, M.; Amaya, A.; Sen, A.; Hasson, H.; Pitts, N.B. The International Caries Detection and Assessment
System (ICDAS): An integrated system for measuring dental caries. Community Dent. Oral Epidemiol. 2007, 35, 170–178. [CrossRef]
36. Pitts, N.B.; Ekstrand, K.R.; Foundation, I. International Caries Detection and Assessment System (ICDAS) and its International
Caries Classification and Management System (ICCMS)—Methods for staging of the caries process and enabling dentists to
manage caries. Community Dent. Oral Epidemiol. 2013, 41, e41–e52. [CrossRef]
37. Adler, C.J.; Dobney, K.; Weyrich, L.S.; Kaidonis, J.; Walker, A.W.; Haak, W.; Bradshaw, C.J.; Townsend, G.; Soltysiak, A.; Alt,
K.W.; et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and
Industrial revolutions. Nat. Genet. 2013, 45, 450–455. [CrossRef]
38. Touger-Decker, R.; van Loveren, C. Sugars and dental caries. Am. J. Clin. Nutr. 2003, 78, 881S–892S. [CrossRef]
39. Toverud, G. Dental caries in Norwegian children during and after the last World War; a preliminary report. Proc. R. Soc. Med.
1949, 42, 249–258. [CrossRef]
40. Sognnaes, R.F. Analysis of wartime reduction of dental caries in European children; with special regard to observations in Norway.
Am. J. Dis. Child. 1948, 75, 792–821. [CrossRef] [PubMed]
41. Krasse, B. The Vipeholm Dental Caries Study: Recollections and reflections 50 years later. J. Dent. Res. 2001, 80, 1785–1788.
[CrossRef] [PubMed]
42. American Academy of Pediatrics; Committee on Native American Child Health, Canadian Paediatric Society; First Nations, Inuit
and Métis Committee. Early childhood caries in indigenous communities. Pediatrics 2011, 127, 1190–1198. [CrossRef] [PubMed]
43. Punitha, V.C.; Amudhan, A.; Sivaprakasam, P.; Rathanaprabu, V. Role of dietary habits and diet in caries occurrence and severity
among urban adolescent school children. J. Pharm. Bioallied Sci. 2015, 7, S296–S300. [CrossRef] [PubMed]
44. Stephan, R.M. Intra-oral hydrogen-ion concentrations associated with dental caries activity. J. Dent. Res. 1944, 23, 257–266.
[CrossRef]
45. Flemming, H.C.; Neu, T.R.; Wozniak, D.J. The EPS matrix: The “house of biofilm cells”. J. Bacteriol. 2007, 189, 7945–7947.
[CrossRef] [PubMed]
46. Harris, R.; Nicoll, A.D.; Adair, P.M.; Pine, C.M. Risk factors for dental caries in young children: A systematic review of the
literature. Community Dent. Health 2004, 21, 71–85. [PubMed]
47. Vieira, A.R.; Modesto, A.; Marazita, M.L. Caries: Review of human genetics research. Caries Res. 2014, 48, 491–506. [CrossRef]
48. Wang, X.; Shaffer, J.R.; Weyant, R.J.; Cuenco, K.T.; DeSensi, R.S.; Crout, R.; McNeil, D.W.; Marazita, M.L. Genes and their effects
on dental caries may differ between primary and permanent dentitions. Caries Res. 2010, 44, 277–284. [CrossRef]
49. Colombo, N.H.; Ribas, L.F.; Pereira, J.A.; Kreling, P.F.; Kressirer, C.A.; Tanner, A.C.; Duque, C. Antimicrobial peptides in saliva of
children with severe early childhood caries. Arch. Oral Biol. 2016, 69, 40–46. [CrossRef]
50. Fourie, N.H.; Wang, D.; Abey, S.K.; Sherwin, L.B.; Joseph, P.V.; Rahim-Williams, B.; Ferguson, E.G.; Henderson, W.A. The
microbiome of the oral mucosa in irritable bowel syndrome. Gut Microbes 2016, 7, 286–301. [CrossRef]
51. Kilian, M.; Chapple, I.L.; Hannig, M.; Marsh, P.D.; Meuric, V.; Pedersen, A.M.; Tonetti, M.S.; Wade, W.G.; Zaura, E. The oral
microbiome—An update for oral healthcare professionals. Br. Dent. J. 2016, 221, 657–666. [CrossRef] [PubMed]
52. Fan, X.; Jin, Y.; Chen, G.; Ma, X.; Zhang, L. Gut microbiota dysbiosis drives the development of colorectal cancer. Digestion 2021,
102, 508–515. [CrossRef] [PubMed]
53. Jeffery, I.B.; Quigley, E.M.; Ohman, L.; Simren, M.; O’Toole, P.W. The microbiota link to irritable bowel syndrome: An emerging
story. Gut Microbes 2012, 3, 572–576. [CrossRef] [PubMed]
54. Gill, S.R.; Pop, M.; Deboy, R.T.; Eckburg, P.B.; Turnbaugh, P.J.; Samuel, B.S.; Gordon, J.I.; Relman, D.A.; Fraser-Liggett, C.M.;
Nelson, K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312, 1355–1359. [CrossRef] [PubMed]
55. Kianoush, N.; Adler, C.J.; Nguyen, K.A.; Browne, G.V.; Simonian, M.; Hunter, N. Bacterial profile of dentine caries and the impact
of pH on bacterial population diversity. PLoS ONE 2014, 9, e92940. [CrossRef]
56. Black, G.V. The Formation of Poisons by Micro-Organisms. A Biological Study of the Germ Theory of Disease; P Blakiston, Son & Co.:
Philadelphia, PA, USA, 1884.
57. Miller, W.D. The Micro-Organisms of the Human Mouth. The Local and General Diseas Which Are Caused by Them; The S. S. White
Dental MFG. Co.: Philadelphia, PA, USA, 1890.
58. Howe, P.R.; Hatch, R.E. A study of the microorganisms of dental caries. J. Med. Res. 1917, 36, 481–492.5. [CrossRef] [PubMed]
59. Rosebury, T. Acid production and tolerance of lactobacilli from dental caries and other sources as measured by the glass electrode.
J. Bacteriol. 1932, 24, 321–334. [CrossRef]
Microorganisms 2024, 12, 121 36 of 45
60. Clarke, J.K. On the bacterial factor in the etiology of dental caries. Br. J. Exp. Pathol. 1924, 5, 141–147.
61. Orland, F.J.; Blayney, J.R.; Harrison, R.W.; Reyniers, J.A.; Trexler, P.C.; Wagner, M.; Gordon, H.A.; Luckey, T.D. Use of the germfree
animal technic in the study of experimental dental caries. I. Basic observations on rats reared free of all microorganisms. J. Dent.
Res. 1954, 33, 147–174. [CrossRef]
62. Keyes, P.H. The infectious and transmissible nature of experimental dental caries. Findings and implications. Arch. Oral Biol.
1960, 1, 304–320. [CrossRef] [PubMed]
63. Fitzgerald, R.J.; Keyes, P.H. Demonstration of the etiologic role of streptococci in experimental caries in the hamster. J. Am. Dent.
Assoc. 1960, 61, 9–19. [CrossRef] [PubMed]
64. Edwardsson, S. Characteristics of caries-inducing human streptococci resembling Streptococcus mutans. Arch. Oral Biol. 1968, 13,
637–646. [CrossRef] [PubMed]
65. Loesche, W.J.; Rowan, J.; Straffon, L.H.; Loos, P.J. Association of Streptococcus mutans with human dental decay. Infect. Immun.
1975, 11, 1252–1260. [CrossRef] [PubMed]
66. Ikeda, T.; Sandham, H.J.; Bradley, E.L., Jr. Changes in Streptococcus mutans and lactobacilli in plaque in relation to the initiation of
dental caries in Negro children. Arch. Oral Biol. 1973, 18, 555–566. [CrossRef] [PubMed]
67. van Houte, J.; Green, D.B. Relationship between the concentration of bacteria in saliva and the colonization of teeth in humans.
Infect. Immun. 1974, 9, 624–630. [CrossRef] [PubMed]
68. Schamschula, R.G.; Charlton, G. A study of caries aetiology in New South Wales schoolchildren. I. The streptococcal flora of
plaque and caries prevalence. Aust. Dent. J. 1971, 16, 77–82. [CrossRef] [PubMed]
69. Marsh, P.D. Dental plaque as a biofilm and a microbial community—Implications for health and disease. BMC Oral Health 2006, 6
(Suppl. S1), S14. [CrossRef]
70. Bradshaw, D.J.; McKee, A.S.; Marsh, P.D. Effects of carbohydrate pulses and pH on population shifts within oral microbial
communities in vitro. J. Dent. Res. 1989, 68, 1298–1302. [CrossRef]
71. Costalonga, M.; Herzberg, M.C. The oral microbiome and the immunobiology of periodontal disease and caries. Immunol. Lett.
2014, 162, 22–38. [CrossRef]
72. Takahashi, N.; Nyvad, B. The role of bacteria in the caries process: Ecological perspectives. J. Dent. Res. 2011, 90, 294–303.
[CrossRef] [PubMed]
73. Takahashi, N.; Nyvad, B. Ecological hypothesis of dentin and root caries. Caries Res. 2016, 50, 422–431. [CrossRef] [PubMed]
74. Kolenbrander, P.E.; Palmer, R.J., Jr.; Periasamy, S.; Jakubovics, N.S. Oral multispecies biofilm development and the key role of
cell–cell distance. Nat. Rev. Microbiol. 2010, 8, 471. [CrossRef] [PubMed]
75. Schweigel, H.; Wicht, M.; Schwendicke, F. Salivary and pellicle proteome: A datamining analysis. Sci. Rep. 2016, 6, 38882.
[CrossRef] [PubMed]
76. Chawhuaveang, D.D.; Yu, O.Y.; Yin, I.X.; Lam, W.Y.; Mei, M.L.; Chu, C.H. Acquired salivary pellicle and oral diseases: A literature
review. J. Dent. Sci. 2021, 16, 523–529. [CrossRef] [PubMed]
77. Marsh, P.D.; Do, T.; Beighton, D.; Devine, D.A. Influence of saliva on the oral microbiota. Periodontology 2000 2016, 70, 80–92.
[CrossRef] [PubMed]
78. Gibbons, R.J.; Hay, D.I.; Childs, W.C., 3rd; Davis, G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces.
Arch. Oral Biol. 1990, 35, 107S–114S. [CrossRef] [PubMed]
79. Jack, A.A.; Daniels, D.E.; Jepson, M.A.; Vickerman, M.M.; Lamont, R.J.; Jenkinson, H.F.; Nobbs, A.H. Streptococcus gordonii
comCDE (competence) operon modulates biofilm formation with Candida albicans. Microbiology 2015, 161, 411–421. [CrossRef]
80. Oguchi, R.; Takahashi, Y.; Shimazu, K.; Urano-Tashiro, Y.; Kawarai, T.; Konishi, K.; Karibe, H. Contribution of Streptococcus
gordonii Hsa Adhesin to Biofilm Formation. Jpn. J. Infect. Dis. 2017, 70, 399–404. [CrossRef]
81. Gibbins, H.L.; Yakubov, G.E.; Proctor, G.B.; Wilson, S.; Carpenter, G.H. What interactions drive the salivary mucosal pellicle
formation? Colloids Surf. B Biointerfaces 2014, 120, 184–192. [CrossRef]
82. Nadell, C.D.; Xavier, J.B.; Levin, S.A.; Foster, K.R. The evolution of quorum sensing in bacterial biofilms. PLoS Biol. 2008, 6, e14.
[CrossRef] [PubMed]
83. Robinson, J.C.; Rostami, N.; Casement, J.; Vollmer, W.; Rickard, A.H.; Jakubovics, N.S. ArcR modulates biofilm formation in the
dental plaque colonizer Streptococcus gordonii. Mol. Oral Microbiol. 2018, 33, 143–154. [CrossRef] [PubMed]
84. Bowen, W.H.; Burne, R.A.; Wu, H.; Koo, H. Oral biofilms: Pathogens, matrix, and polymicrobial interactions in microenvironments.
Trends Microbiol. 2018, 26, 229–242. [CrossRef] [PubMed]
85. Sethi, A.; Mohanty, B.; Ramasubbu, N.; Gooley, P.R. Structure of amylase-binding protein A of Streptococcus gordonii: A potential
receptor for human salivary alpha-amylase enzyme. Protein Sci. 2015, 24, 1013–1018. [CrossRef] [PubMed]
86. Huang, R.; Li, M.; Gregory, R.L. Bacterial interactions in dental biofilm. Virulence 2011, 2, 435–444. [CrossRef]
87. Haase, E.M.; Kou, Y.; Sabharwal, A.; Liao, Y.C.; Lan, T.; Lindqvist, C.; Scannapieco, F.A. Comparative genomics and evolution of
the amylase-binding proteins of oral streptococci. BMC Microbiol. 2017, 17, 94. [CrossRef]
88. Burne, R.A.; Marquis, R.E. Alkali production by oral bacteria and protection against dental caries. FEMS Microbiol. Lett. 2000, 193,
1–6. [CrossRef]
89. Nascimento, M.M.; Browngardt, C.; Xiaohui, X.; Klepac-Ceraj, V.; Paster, B.J.; Burne, R.A. The effect of arginine on oral biofilm
communities. Mol. Oral Microbiol. 2014, 29, 45–54. [CrossRef]
Microorganisms 2024, 12, 121 37 of 45
90. Huang, X.; Palmer, S.; Ahn, S.J.; Richards, V.P.; Williams, M.L.; Nascimento, M.M.; Burne, R.A. Characterization of a highly
arginolytic Streptococcus species that potently antagonizes Streptococcus mutans. Appl. Environ. Microbiol. 2016, 82, 2187–2201.
[CrossRef]
91. Mashima, I.; Nakazawa, F. Identification of Veillonella tobetsuensis in tongue biofilm by using a species-specific primer pair.
Anaerobe 2013, 22, 77–81. [CrossRef]
92. Mashima, I.; Nakazawa, F. The interaction between Streptococcus spp. and Veillonella tobetsuensis in the early stages of oral biofilm
formation. J. Bacteriol. 2015, 197, 2104–2111. [CrossRef] [PubMed]
93. Listgarten, M.A. Structure of the microbial flora associated with periodontal health and disease in man. A light and electron
microscopic study. J. Periodontol. 1976, 47, 1–18. [CrossRef] [PubMed]
94. Kolenbrander, P.E.; Andersen, R.N.; Blehert, D.S.; Egland, P.G.; Foster, J.S.; Palmer, R.J., Jr. Communication among oral bacteria.
Microbiol. Mol. Biol. Rev. 2002, 66, 486–505. [CrossRef] [PubMed]
95. Forssten, S.D.; Bjorklund, M.; Ouwehand, A.C. Streptococcus mutans, caries and simulation models. Nutrients 2010, 2, 290–298.
[CrossRef] [PubMed]
96. Moye, Z.D.; Zeng, L.; Burne, R.A. Fueling the caries process: Carbohydrate metabolism and gene regulation by Streptococcus
mutans. J. Oral Microbiol. 2014, 6, 24878. [CrossRef] [PubMed]
97. Jakubovics, N.S. Intermicrobial interactions as a driver for community composition and stratification of oral biofilms. J. Mol. Biol.
2015, 427, 3662–3675. [CrossRef] [PubMed]
98. Yang, J.; Yoshida, Y.; Cisar, J.O. Genetic basis of coaggregation receptor polysaccharide biosynthesis in Streptococcus sanguinis and
related species. Mol. Oral Microbiol. 2014, 29, 24–31. [CrossRef]
99. Simon-Soro, A.; Mira, A. Solving the etiology of dental caries. Trends Microbiol. 2015, 23, 76–82. [CrossRef]
100. Loesche, W.J.; Syed, S.A. The predominant cultivable flora of carious plaque and carious dentine. Caries Res. 1973, 7, 201–216.
[CrossRef]
101. Svensater, G.; Borgstrom, M.; Bowden, G.H.; Edwardsson, S. The acid-tolerant microbiota associated with plaque from initial
caries and healthy tooth surfaces. Caries Res. 2003, 37, 395–403. [CrossRef]
102. Marchant, S.; Brailsford, S.R.; Twomey, A.C.; Roberts, G.J.; Beighton, D. The predominant microflora of nursing caries lesions.
Caries Res. 2001, 35, 397–406. [CrossRef]
103. Manganiello, A.D.; Socransky, S.S.; Smith, C.; Propas, D.; Oram, V.; Dogon, I.L. Attempts to increase viable count recovery of
human supragingival dental plaque. J. Periodontal Res. 1977, 12, 107–119. [CrossRef] [PubMed]
104. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486,
207–214. [CrossRef] [PubMed]
105. Dewhirst, F.E.; Chen, T.; Izard, J.; Paster, B.J.; Tanner, A.C.; Yu, W.H.; Lakshmanan, A.; Wade, W.G. The human oral microbiome. J.
Bacteriol. 2010, 192, 5002–5017. [CrossRef] [PubMed]
106. Becker, M.R.; Paster, B.J.; Leys, E.J.; Moeschberger, M.L.; Kenyon, S.G.; Galvin, J.L.; Boches, S.K.; Dewhirst, F.E.; Griffen, A.L.
Molecular analysis of bacterial species associated with childhood caries. J. Clin. Microbiol. 2002, 40, 1001–1009. [CrossRef]
[PubMed]
107. Corby, P.M.; Lyons-Weiler, J.; Bretz, W.A.; Hart, T.C.; Aas, J.A.; Boumenna, T.; Goss, J.; Corby, A.L.; Junior, H.M.; Weyant, R.J.; et al.
Microbial risk indicators of early childhood caries. J. Clin. Microbiol. 2005, 43, 5753–5759. [CrossRef] [PubMed]
108. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol.
2005, 43, 5721–5732. [CrossRef] [PubMed]
109. Li, Y.; Ge, Y.; Saxena, D.; Caufield, P.W. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J.
Clin. Microbiol. 2007, 45, 81–87. [CrossRef] [PubMed]
110. Gross, E.L.; Beall, C.J.; Kutsch, S.R.; Firestone, N.D.; Leys, E.J.; Griffen, A.L. Beyond Streptococcus mutans: Dental caries onset
linked to multiple species by 16S rRNA community analysis. PLoS ONE 2012, 7, e47722. [CrossRef]
111. Munson, M.A.; Banerjee, A.; Watson, T.F.; Wade, W.G. Molecular analysis of the microflora associated with dental caries. J. Clin.
Microbiol. 2004, 42, 3023–3029. [CrossRef]
112. Kanasi, E.; Dewhirst, F.E.; Chalmers, N.I.; Kent, R., Jr.; Moore, A.; Hughes, C.V.; Pradhan, N.; Loo, C.Y.; Tanner, A.C. Clonal
analysis of the microbiota of severe early childhood caries. Caries Res. 2010, 44, 485–497. [CrossRef] [PubMed]
113. Tanner, A.C.; Mathney, J.M.; Kent, R.L.; Chalmers, N.I.; Hughes, C.V.; Loo, C.Y.; Pradhan, N.; Kanasi, E.; Hwang, J.; Dahlan,
M.A.; et al. Cultivable anaerobic microbiota of severe early childhood caries. J. Clin. Microbiol. 2011, 49, 1464–1474. [CrossRef]
[PubMed]
114. Tanner, A.C.R.; Kressirer, C.A.; Rothmiller, S.; Johansson, I.; Chalmers, N.I. The caries microbiome: Implications for reversing
dysbiosis. Adv. Dent. Res. 2018, 29, 78–85. [CrossRef] [PubMed]
115. Schulze-Schweifing, K.; Banerjee, A.; Wade, W.G. Comparison of bacterial culture and 16S rRNA community profiling by clonal
analysis and pyrosequencing for the characterization of the dentine caries-associated microbiome. Front. Cell. Infect. Microbiol.
2014, 4, 164. [CrossRef] [PubMed]
116. Buermans, H.P.; den Dunnen, J.T. Next generation sequencing technology: Advances and applications. Biochim. Biophys. Acta
2014, 1842, 1932–1941. [CrossRef] [PubMed]
117. Ji, B.; Nielsen, J. From next-generation sequencing to systematic modeling of the gut microbiome. Front. Genet. 2015, 6, 219.
[CrossRef] [PubMed]
Microorganisms 2024, 12, 121 38 of 45
118. Vincent, A.T.; Derome, N.; Boyle, B.; Culley, A.I.; Charette, S.J. Next-generation sequencing (NGS) in the microbiological world:
How to make the most of your money. J. Microbiol. Methods 2017, 138, 60–71. [CrossRef]
119. Hardie, J.M.; Thomson, P.L.; South, R.J.; Marsh, P.D.; Bowden, G.H.; McKee, A.S.; Fillery, E.D.; Slack, G.L. A longitudinal
epidemiological study on dental plaque and the development of dental caries–interim results after two years. J. Dent. Res. 1977,
56, C90–C98. [CrossRef]
120. van Houte, J.; Sansone, C.; Joshipura, K.; Kent, R. In vitro acidogenic potential and mutans streptococci of human smooth-surface
plaque associated with initial caries lesions and sound enamel. J. Dent. Res. 1991, 70, 1497–1502. [CrossRef]
121. Boyar, R.M.; Thylstrup, A.; Holmen, L.; Bowden, G.H. The microflora associated with the development of initial enamel
decalcification below orthodontic bands in vivo in children living in a fluoridated-water area. J. Dent. Res. 1989, 68, 1734–1738.
[CrossRef]
122. Tanner, A.C.; Sonis, A.L.; Lif Holgerson, P.; Starr, J.R.; Nunez, Y.; Kressirer, C.A.; Paster, B.J.; Johansson, I. White-spot lesions and
gingivitis microbiotas in orthodontic patients. J. Dent. Res. 2012, 91, 853–858. [CrossRef] [PubMed]
123. Torlakovic, L.; Klepac-Ceraj, V.; Ogaard, B.; Cotton, S.L.; Paster, B.J.; Olsen, I. Microbial community succession on developing
lesions on human enamel. J. Oral Microbiol. 2012, 4, e16125. [CrossRef] [PubMed]
124. Aas, J.A.; Griffen, A.L.; Dardis, S.R.; Lee, A.M.; Olsen, I.; Dewhirst, F.E.; Leys, E.J.; Paster, B.J. Bacteria of dental caries in primary
and permanent teeth in children and young adults. J. Clin. Microbiol. 2008, 46, 1407–1417. [CrossRef] [PubMed]
125. Kim, D.; Barraza, J.P.; Arthur, R.A.; Hara, A.; Lewis, K.; Liu, Y.; Scisci, E.L.; Hajishengallis, E.; Whiteley, M.; Koo, H. Spatial
mapping of polymicrobial communities reveals a precise biogeography associated with human dental caries. Proc. Natl. Acad. Sci.
USA 2020, 117, 12375–12386. [CrossRef]
126. Syed, S.A.; Loesche, W.J.; Pape, H.L., Jr.; Grenier, E. Predominant cultivable flora isolated from human root surface caries plaque.
Infect. Immun. 1975, 11, 727–731. [CrossRef]
127. van Houte, J.; Lopman, J.; Kent, R. The final pH of bacteria comprising the predominant flora on sound and carious human root
and enamel surfaces. J. Dent. Res. 1996, 75, 1008–1014. [CrossRef]
128. Brailsford, S.R.; Shah, B.; Simons, D.; Gilbert, S.; Clark, D.; Ines, I.; Adams, S.E.; Allison, C.; Beighton, D. The predominant
aciduric microflora of root-caries lesions. J. Dent. Res. 2001, 80, 1828–1833. [CrossRef]
129. Ikebe, K.; Imazato, S.; Izutani, N.; Matsuda, K.; Ebisu, S.; Nokubi, T.; Walls, A.W. Association of salivary Streptococcus mutans
levels determined by rapid detection system using monoclonal antibodies with prevalence of root surface caries. Am. J. Dent.
2008, 21, 283–287.
130. Mantzourani, M.; Fenlon, M.; Beighton, D. Association between Bifidobacteriaceae and the clinical severity of root caries lesions.
Oral Microbiol. Immunol. 2009, 24, 32–37. [CrossRef]
131. Hashimoto, K.; Sato, T.; Shimauchi, H.; Takahashi, N. Profiling of dental plaque microflora on root caries lesions and the
protein-denaturing activity of these bacteria. Am. J. Dent. 2011, 24, 295–299.
132. Shen, S.; Samaranayake, L.P.; Yip, H.K.; Dyson, J.E. Bacterial and yeast flora of root surface caries in elderly, ethnic Chinese. Oral
Dis. 2002, 8, 207–217. [CrossRef] [PubMed]
133. Preza, D.; Olsen, I.; Willumsen, T.; Boches, S.K.; Cotton, S.L.; Grinde, B.; Paster, B.J. Microarray analysis of the microflora of root
caries in elderly. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 2009, 28, 509–517. [CrossRef] [PubMed]
134. Chen, L.; Qin, B.; Du, M.; Zhong, H.; Xu, Q.; Li, Y.; Zhang, P.; Fan, M. Extensive description and comparison of human
supra-gingival microbiome in root caries and health. PLoS ONE 2015, 10, e0117064. [CrossRef]
135. Dame-Teixeira, N.; Parolo, C.C.; Maltz, M.; Tugnait, A.; Devine, D.; Do, T. Actinomyces spp. gene expression in root caries lesions.
J. Oral Microbiol. 2016, 8, 32383. [CrossRef]
136. Lima, K.C.; Coelho, L.T.; Pinheiro, I.V.; Rocas, I.N.; Siqueira, J.F., Jr. Microbiota of dentinal caries as assessed by reverse-capture
checkerboard analysis. Caries Res. 2011, 45, 21–30. [CrossRef]
137. Liu, G.; Wu, C.; Abrams, W.R.; Li, Y. Structural and functional characteristics of the microbiome in deep-dentin caries. J. Dent. Res.
2020, 99, 713–720. [CrossRef] [PubMed]
138. Chhour, K.L.; Nadkarni, M.A.; Byun, R.; Martin, F.E.; Jacques, N.A.; Hunter, N. Molecular analysis of microbial diversity in
advanced caries. J. Clin. Microbiol. 2005, 43, 843–849. [CrossRef] [PubMed]
139. Kuribayashi, M.; Kitasako, Y.; Matin, K.; Sadr, A.; Shida, K.; Tagami, J. Intraoral pH measurement of carious lesions with qPCR of
cariogenic bacteria to differentiate caries activity. J. Dent. 2012, 40, 222–228. [CrossRef]
140. Kianoush, N.; Nguyen, K.A.; Browne, G.V.; Simonian, M.; Hunter, N. pH gradient and distribution of streptococci, lactobacilli,
prevotellae, and fusobacteria in carious dentine. Clin. Oral Investig. 2014, 18, 659–669. [CrossRef]
141. Do, T.; Dame-Teixeira, N.; Naginyte, M.; Marsh, P.D. Root surface biofilms and caries. Monogr. Oral Sci. 2017, 26, 26–34. [CrossRef]
142. Kressirer, C.A.; Chen, T.; Lake Harriman, K.; Frias-Lopez, J.; Dewhirst, F.E.; Tavares, M.A.; Tanner, A.C. Functional profiles of
coronal and dentin caries in children. J. Oral Microbiol. 2018, 10, 1495976. [CrossRef] [PubMed]
143. Milnes, A.R.; Bowden, G.H. The microflora associated with developing lesions of nursing caries. Caries Res. 1985, 19, 289–297.
[CrossRef]
144. Berkowitz, R.J.; Jordan, H.V. Similarity of bacteriocins of Streptococcus mutans from mother and infant. Arch. Oral Biol. 1975, 20,
725–730. [CrossRef]
145. Li, Y.; Caufield, P.W. The fidelity of initial acquisition of mutans streptococci by infants from their mothers. J. Dent. Res. 1995, 74,
681–685. [CrossRef] [PubMed]
Microorganisms 2024, 12, 121 39 of 45
146. Kohler, B.; Lundberg, A.B.; Birkhed, D.; Papapanou, P.N. Longitudinal study of intrafamilial mutans streptococci ribotypes. Eur. J.
Oral Sci. 2003, 111, 383–389. [CrossRef] [PubMed]
147. Tanner, A.C.; Kent, R.L., Jr.; Holgerson, P.L.; Hughes, C.V.; Loo, C.Y.; Kanasi, E.; Chalmers, N.I.; Johansson, I. Microbiota of severe
early childhood caries before and after therapy. J. Dent. Res. 2011, 90, 1298–1305. [CrossRef] [PubMed]
148. Hughes, C.V.; Dahlan, M.; Papadopolou, E.; Loo, C.Y.; Pradhan, N.S.; Lu, S.C.; Mathney, J.M.; Bravoco, A.; Kent, R.L., Jr.; Tanner,
A.C. Aciduric microbiota and mutans streptococci in severe and recurrent severe early childhood caries. Pediatr. Dent. 2012, 34,
e16–e23.
149. Warren, J.J.; Blanchette, D.; Dawson, D.V.; Marshall, T.A.; Phipps, K.R.; Starr, D.; Drake, D.R. Factors associated with dental caries
in a group of American Indian children at age 36 months. Community Dent. Oral Epidemiol. 2016, 44, 154–161. [CrossRef]
150. Batliner, T.; Wilson, A.R.; Tiwari, T.; Glueck, D.; Henderson, W.; Thomas, J.; Braun, P.; Cudeii, D.; Quissell, D.; Albino, J. Oral
health status in Navajo Nation Head Start children. J. Public Health Dent. 2014, 74, 317–325. [CrossRef]
151. Agnello, M.; Marques, J.; Cen, L.; Mittermuller, B.; Huang, A.; Chaichanasakul Tran, N.; Shi, W.; He, X.; Schroth, R.J. Microbiome
associated with severe caries in Canadian First Nations children. J. Dent. Res. 2017, 96, 1378–1385. [CrossRef]
152. Villhauer, A.L.; Lynch, D.J.; Warren, J.J.; Dawson, D.V.; Blanchette, D.R.; Drake, D.R. Genotypic characterization and comparison
of Streptococcus mutans in American Indian and Southeast Iowa children. Clin. Exp. Dent. Res. 2017, 3, 235–243. [CrossRef]
153. Johansson, I.; Witkowska, E.; Kaveh, B.; Lif Holgerson, P.; Tanner, A.C. The microbiome in populations with a low and high
prevalence of caries. J. Dent. Res. 2016, 95, 80–86. [CrossRef] [PubMed]
154. Eriksson, L.; Lif Holgerson, P.; Esberg, A.; Johansson, I. Microbial complexes and caries in 17-year-olds with and without
Streptococcus mutans. J. Dent. Res. 2018, 97, 275–282. [CrossRef] [PubMed]
155. Thomas, R.Z.; Zijnge, V.; Cicek, A.; de Soet, J.J.; Harmsen, H.J.; Huysmans, M.C. Shifts in the microbial population in relation to in
situ caries progression. Caries Res. 2012, 46, 427–431. [CrossRef]
156. Falsetta, M.L.; Klein, M.I.; Colonne, P.M.; Scott-Anne, K.; Gregoire, S.; Pai, C.H.; Gonzalez-Begne, M.; Watson, G.; Krysan, D.J.;
Bowen, W.H.; et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque
biofilms in vivo. Infect. Immun. 2014, 82, 1968–1981. [CrossRef] [PubMed]
157. Xiao, J.; Huang, X.; Alkhers, N.; Alzamil, H.; Alzoubi, S.; Wu, T.T.; Castillo, D.A.; Campbell, F.; Davis, J.; Herzog, K.; et al. Candida
albicans and early childhood caries: A systematic review and meta-analysis. Caries Res. 2018, 52, 102–112. [CrossRef]
158. Janus, M.M.; Crielaard, W.; Volgenant, C.M.; van der Veen, M.H.; Brandt, B.W.; Krom, B.P. Candida albicans alters the bacterial
microbiome of early in vitro oral biofilms. J. Oral Microbiol. 2017, 9, 1270613. [CrossRef]
159. Diaz, P.I.; Xie, Z.; Sobue, T.; Thompson, A.; Biyikoglu, B.; Ricker, A.; Ikonomou, L.; Dongari-Bagtzoglou, A. Synergistic interaction
between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect. Immun. 2012, 80, 620–632.
[CrossRef]
160. Metwalli, K.H.; Khan, S.A.; Krom, B.P.; Jabra-Rizk, M.A. Streptococcus mutans, Candida albicans, and the human mouth: A sticky
situation. PLoS Pathog. 2013, 9, e1003616. [CrossRef]
161. He, J.; Kim, D.; Zhou, X.; Ahn, S.J.; Burne, R.A.; Richards, V.P.; Koo, H. RNA-Seq reveals enhanced sugar metabolism in
Streptococcus mutans co-cultured with Candida albicans within mixed-species biofilms. Front. Microbiol. 2017, 8, 1036. [CrossRef]
162. Kneist, S.; Borutta, A.; Sigusch, B.W.; Nietzsche, S.; Kupper, H.; Kostrzewa, M.; Callaway, A. First-time isolation of Candida
dubliniensis from plaque and carious dentine of primary teeth. Eur. Arch. Paediatr. Dent. 2015, 16, 365–370. [CrossRef] [PubMed]
163. Al-Ahmad, A.; Auschill, T.M.; Dakhel, R.; Wittmer, A.; Pelz, K.; Heumann, C.; Hellwig, E.; Arweiler, N.B. Prevalence of Candida
albicans and Candida dubliniensis in caries-free and caries-active children in relation to the oral microbiota-a clinical study. Clin.
Oral Investig. 2016, 20, 1963–1971. [CrossRef] [PubMed]
164. Xiao, J.; Grier, A.; Faustoferri, R.C.; Alzoubi, S.; Gill, A.L.; Feng, C.; Liu, Y.; Quivey, R.G.; Kopycka-Kedzierawski, D.T.; Koo,
H.; et al. Association between oral candida and bacteriome in children with severe ECC. J. Dent. Res. 2018, 97, 1468–1476.
[CrossRef] [PubMed]
165. van Houte, J. Role of micro-organisms in caries etiology. J. Dent. Res. 1994, 73, 672–681. [CrossRef] [PubMed]
166. Colby, S.M.; Russell, R.R.B. Sugar metabolism by mutans streptococci. J. Appl. Microbiol. 1997, 83, 80S–88S. [CrossRef] [PubMed]
167. Argimon, S.; Konganti, K.; Chen, H.; Alekseyenko, A.V.; Brown, S.; Caufield, P.W. Comparative genomics of oral isolates of
Streptococcus mutans by in silico genome subtraction does not reveal accessory DNA associated with severe early childhood caries.
Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2014, 21C, 269–278. [CrossRef]
168. Argimon, S.; Caufield, P.W. Distribution of putative virulence genes in Streptococcus mutans strains does not correlate with caries
experience. J. Clin. Microbiol. 2011, 49, 984–992. [CrossRef]
169. Palmer, S.R.; Miller, J.H.; Abranches, J.; Zeng, L.; Lefebure, T.; Richards, V.P.; Lemos, J.A.; Stanhope, M.J.; Burne, R.A. Phenotypic
heterogeneity of genomically-diverse isolates of Streptococcus mutans. PLoS ONE 2013, 8, e61358. [CrossRef]
170. Esberg, A.; Sheng, N.; Marell, L.; Claesson, R.; Persson, K.; Boren, T.; Stromberg, N. Streptococcus mutans adhesin biotypes that
match and predict individual caries development. EBioMedicine 2017, 24, 205–215. [CrossRef]
171. Aviles-Reyes, A.; Miller, J.H.; Simpson-Haidaris, P.J.; Lemos, J.A.; Abranches, J. Cnm is a major virulence factor of invasive
Streptococcus mutans and part of a conserved three-gene locus. Mol. Oral Microbiol. 2014, 29, 11–23. [CrossRef]
172. Rainey, K.; Michalek, S.M.; Wen, Z.T.; Wu, H. Glycosyltransferase mediated biofilm matrix dynamics and virulence of Streptococ-
cus mutans. Appl. Environ. Microbiol. 2019, 85, e02247-18. [CrossRef] [PubMed]
Microorganisms 2024, 12, 121 40 of 45
173. Kleinberg, I. A mixed-bacteria ecological approach to understanding the role of the oral bacteria in dental caries causation: An
alternative to Streptococcus mutans and the specific-plaque hypothesis. Crit. Rev. Oral Biol. Med. 2002, 13, 108–125. [CrossRef]
[PubMed]
174. Bowden, G.H. Does assessment of microbial composition of plaque/saliva allow for diagnosis of disease activity of individuals?
Community Dent. Oral Epidemiol. 1997, 25, 76–81. [CrossRef] [PubMed]
175. Coeuret, V.; Dubernet, S.; Bernardeau, M.; Gueguen, M.; Vernoux, J.P. Isolation, characterisation and identification of lactobacilli
focusing mainly on cheeses and other dairy products. Lait 2003, 83, 269–306. [CrossRef]
176. Samot, J.; Lebreton, J.; Badet, C. Adherence capacities of oral lactobacilli for potential probiotic purposes. Anaerobe 2011, 17, 69–72.
[CrossRef]
177. van Pijkeren, J.P.; O’Toole, P.W. Comparative and functional genomics of the genus Lactobacillus. In Lactobacillus Molecular Biology
from Genomics to Probiotics; Ljungh, A., Wadstrom, T., Eds.; Caister Academic Press: Norfold, UK, 2009; pp. 59–82.
178. Badet, C.; Thebaud, N.B. Ecology of lactobacilli in the oral cavity: A review of literature. Open Microbiol. J. 2008, 2, 38–48.
[CrossRef]
179. Plonka, K.A.; Pukallus, M.L.; Barnett, A.G.; Walsh, L.J.; Holcombe, T.H.; Seow, W.K. Mutans streptococci and lactobacilli
colonization in predentate children from the neonatal period to seven months of age. Caries Res. 2012, 46, 213–220. [CrossRef]
180. Nelun Barfod, M.; Magnusson, K.; Lexner, M.O.; Blomqvist, S.; Dahlen, G.; Twetman, S. Oral microflora in infants delivered
vaginally and by caesarean section. Int. J. Paediatr. Dent./Br. Paedodontic Soc. Int. Assoc. Dent. Child. 2011, 21, 401–406. [CrossRef]
181. Holgerson, P.L.; Vestman, N.R.; Claesson, R.; Ohman, C.; Domellof, M.; Tanner, A.C.; Hernell, O.; Johansson, I. Oral microbial
profile discriminates breast-fed from formula-fed infants. J. Pediatr. Gastroenterol. Nutr. 2013, 56, 127–136. [CrossRef]
182. Teanpaisan, R.; Chaethong, W.; Piwat, S.; Thitasomakul, S. Vertical transmission of mutans streptococci and lactobacilli in Thai
families. Pediatr. Dent. 2012, 34, e24–e29.
183. Teanpaisan, R.; Thitasomakul, S.; Piwat, S.; Thearmontree, A.; Pithpornchaiyakul, W.; Chankanka, O. Longitudinal study of the
presence of mutans streptococci and lactobacilli in relation to dental caries development in 3–24 month old Thai children. Int.
Dent. J. 2007, 57, 445–451. [CrossRef] [PubMed]
184. Loesche, W.J.; Eklund, S.; Earnest, R.; Burt, B. Longitudinal investigation of bacteriology of human fissure decay: Epidemiological
studies in molars shortly after eruption. Infect. Immun. 1984, 46, 765–772. [CrossRef] [PubMed]
185. Roeters, F.J.; van der Hoeven, J.S.; Burgersdijk, R.C.; Schaeken, M.J. Lactobacilli, mutants streptococci and dental caries: A
longitudinal study in 2-year-old children up to the age of 5 years. Caries Res. 1995, 29, 272–279. [CrossRef] [PubMed]
186. Kanasi, E.; Johansson, I.; Lu, S.C.; Kressin, N.R.; Nunn, M.E.; Kent, R., Jr.; Tanner, A.C. Microbial risk markers for childhood caries
in pediatricians’ offices. J. Dent. Res. 2010, 89, 378–383. [CrossRef] [PubMed]
187. Caufield, P.W.; Li, Y.; Dasanayake, A.; Saxena, D. Diversity of lactobacilli in the oral cavities of young women with dental caries.
Caries Res. 2007, 41, 2–8. [CrossRef] [PubMed]
188. Yang, R.; Argimon, S.; Li, Y.; Gu, H.; Zhou, X.; Caufield, P.W. Determining the genetic diversity of lactobacilli from the oral cavity.
J. Microbiol. Methods 2010, 82, 163–169. [CrossRef] [PubMed]
189. Argimon, S.; Casey, S.; Saraithong, P.; Schon, C.; Li, Y.; Caufield, P. Comparison of bacterial culture and culture-independent 16S
rRNA gene sequencing for the study of Lactobacillus diversity in children with severe early childhood caries. In Proceedings of
the 5th ASM Conference on Beneficial Microbes, Washington, DC, USA, 27–30 September 2014.
190. Kneist, S.; Schmidt, F.; Callaway, A.; Willershausen, B.; Rupf, S.; Wicht, M.; Thiede, B. Diversity of Lactobacillus species in deep
carious lesions of primary molars. Eur. Arch. Paediatr. Dent. 2010, 11, 181–186. [CrossRef] [PubMed]
191. Rocas, I.N.; Alves, F.R.; Rachid, C.T.; Lima, K.C.; Assuncao, I.V.; Gomes, P.N.; Siqueira, J.F., Jr. Microbiome of deep dentinal caries
lesions in teeth with symptomatic irreversible pulpitis. PLoS ONE 2016, 11, e0154653. [CrossRef]
192. Caufield, P.W.; Schon, C.N.; Saraithong, P.; Li, Y.; Argimon, S. Oral lactobacilli and dental caries: A model for niche adaptation in
humans. J. Dent. Res. 2015, 94, 110S–118S. [CrossRef]
193. Twetman, S.; Fritzon, B.; Jensen, B.; Hallberg, U.; Stahl, B. Pre- and post-treatment levels of salivary mutans streptococci and
lactobacilli in pre-school children. Int. J. Paediatr. Dent./Br. Paedodontic Soc. Int. Assoc. Dent. Child. 1999, 9, 93–98. [CrossRef]
194. Klinke, T.; Urban, M.; Luck, C.; Hannig, C.; Kuhn, M.; Kramer, N. Changes in Candida spp., mutans streptococci and lactobacilli
following treatment of early childhood caries: A 1-year follow-up. Caries Res. 2014, 48, 24–31. [CrossRef]
195. Callaway, A.; Kostrzewa, M.; Willershausen, B.; Schmidt, F.; Thiede, B.; Kupper, H.; Kneist, S. Identification of lactobacilli from
deep carious lesions by means of species-specific PCR and MALDI-TOF mass spectrometry. Clin. Lab. 2013, 59, 1373–1379.
[CrossRef]
196. Dasanayake, A.P.; Chhun, N.; Tanner, A.C.; Craig, R.G.; Lee, M.J.; Moore, A.F.; Norman, R.G. Periodontal pathogens and
gestational diabetes mellitus. J. Dent. Res. 2008, 87, 328–333. [CrossRef]
197. Harper, D.S.; Loesche, W.J. Growth and acid tolerance of human dental plaque bacteria. Arch. Oral Biol. 1984, 29, 843–848.
[CrossRef]
198. Behbehani, M.J.; Jordan, H.V.; Heeley, J.D. Oral colonization and pathogenicity of Actinomyces israelii in gnotobiotic rats. J. Dent.
Res. 1983, 62, 69–74. [CrossRef]
199. van Houte, J.; van Palenstein-Helderman, W.H. Cariogenic potential of Bifidobacterium in gnotobiotic rats. J. Dent. Res. 1980, 59,
1176. [CrossRef]
Microorganisms 2024, 12, 121 41 of 45
200. Kressirer, C.A.; Smith, D.J.; King, W.F.; Dobeck, J.M.; Starr, J.K.; Tanner, A.C. Scardovia wiggsiae and its potential role as a caries
pathogen. J. Oral Biosci. 2017, 59, 135–141. [CrossRef]
201. Mantzourani, M.; Gilbert, S.C.; Sulong, H.N.; Sheehy, E.C.; Tank, S.; Fenlon, M.; Beighton, D. The isolation of bifidobacteria from
occlusal carious lesions in children and adults. Caries Res. 2009, 43, 308–313. [CrossRef]
202. Kaur, R.; Gilbert, S.C.; Sheehy, E.C.; Beighton, D. Salivary levels of bifidobacteria in caries-free and caries-active children. Int. J.
Paediatr. Dent./Br. Paedodontic Soc. Int. Assoc. Dent. Child. 2013, 23, 32–38. [CrossRef]
203. de Matos, B.M.; Brighenti, F.L.; Do, T.; Beighton, D.; Koga-Ito, C.Y. Acidogenicity of dual-species biofilms of bifidobacteria and
Streptococcus mutans. Clin. Oral Investig. 2017, 21, 1769–1776. [CrossRef]
204. Alcaraz, L.D.; Belda-Ferre, P.; Cabrera-Rubio, R.; Romero, H.; Simon-Soro, A.; Pignatelli, M.; Mira, A. Identifying a healthy oral
microbiome through metagenomics. Clin. Microbiol. Infect. 2012, 18 (Suppl. S4), 54–57. [CrossRef]
205. Peterson, S.N.; Snesrud, E.; Schork, N.J.; Bretz, W.A. Dental caries pathogenicity: A genomic and metagenomic perspective. Int.
Dent. J. 2011, 61 (Suppl. S1), 11–22. [CrossRef]
206. Vaishampayan, P.A.; Kuehl, J.V.; Froula, J.L.; Morgan, J.L.; Ochman, H.; Francino, M.P. Comparative metagenomics and population
dynamics of the gut microbiota in mother and infant. Genome Biol. Evol. 2010, 2, 53–66. [CrossRef]
207. Thomas, T.; Gilbert, J.; Meyer, F. Metagenomics—A guide from sampling to data analysis. Microb. Inform. Exp. 2012, 2, 3.
[CrossRef]
208. Wang, W.L.; Xu, S.Y.; Ren, Z.G.; Tao, L.; Jiang, J.W.; Zheng, S.S. Application of metagenomics in the human gut microbiome. World
J. Gastroenterol. 2015, 21, 803–814. [CrossRef]
209. Jovel, J.; Patterson, J.; Wang, W.; Hotte, N.; O’Keefe, S.; Mitchel, T.; Perry, T.; Kao, D.; Mason, A.L.; Madsen, K.L.; et al.
Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics. Front. Microbiol. 2016, 7, 459. [CrossRef]
210. Xu, P.; Gunsolley, J. Application of metagenomics in understanding oral health and disease. Virulence 2014, 5, 424–432. [CrossRef]
211. Wang, J.; Qi, J.; Zhao, H.; He, S.; Zhang, Y.; Wei, S.; Zhao, F. Metagenomic sequencing reveals microbiota and its functional
potential associated with periodontal disease. Sci. Rep. 2013, 3, 1843. [CrossRef]
212. Xie, G.; Chain, P.S.; Lo, C.C.; Liu, K.L.; Gans, J.; Merritt, J.; Qi, F. Community and gene composition of a human dental plaque
microbiota obtained by metagenomic sequencing. Mol. Oral Microbiol. 2010, 25, 391–405. [CrossRef]
213. Belda-Ferre, P.; Alcaraz, L.D.; Cabrera-Rubio, R.; Romero, H.; Simon-Soro, A.; Pignatelli, M.; Mira, A. The oral metagenome in
health and disease. ISME J. 2012, 6, 46–56. [CrossRef]
214. Takahashi, N.; Yamada, T. Effects of pH on the glucose and lactate metabolisms by the washed cells of Actinomyces naeslundii
under anaerobic and aerobic conditions. Oral Microbiol. Immunol. 1999, 14, 60–65. [CrossRef]
215. Lemos, J.A.; Abranches, J.; Burne, R.A. Responses of cariogenic streptococci to environmental stresses. Curr. Issues Mol. Biol. 2005,
7, 95–107.
216. Jorth, P.; Turner, K.H.; Gumus, P.; Nizam, N.; Buduneli, N.; Whiteley, M. Metatranscriptomics of the human oral microbiome
during health and disease. mBio 2014, 5, e01012–e01014. [CrossRef]
217. Takahashi, N. Oral microbiome metabolism: From “Who Are They?” to “What Are They Doing?”. J. Dent. Res. 2015, 94, 1628–1637.
[CrossRef]
218. Simon-Soro, A.; Guillen-Navarro, M.; Mira, A. Metatranscriptomics reveals overall active bacterial composition in caries lesions.
J. Oral Microbiol. 2014, 6, 25443. [CrossRef]
219. Hajishengallis, G.; Darveau, R.P.; Curtis, M.A. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 2012, 10, 717–725.
[CrossRef]
220. Peterson, S.N.; Meissner, T.; Su, A.I.; Snesrud, E.; Ong, A.C.; Schork, N.J.; Bretz, W.A. Functional expression of dental plaque
microbiota. Front. Cell. Infect. Microbiol. 2014, 4, 108. [CrossRef]
221. May, A.; Brandt, B.W.; El-Kebir, M.; Klau, G.W.; Zaura, E.; Crielaard, W.; Heringa, J.; Abeln, S. metaModules identifies key
functional subnetworks in microbiome-related disease. Bioinformatics 2016, 32, 1678–1685. [CrossRef]
222. Belstrom, D.; Constancias, F.; Liu, Y.; Yang, L.; Drautz-Moses, D.I.; Schuster, S.C.; Kohli, G.S.; Jakobsen, T.H.; Holmstrup, P.;
Givskov, M. Metagenomic and metatranscriptomic analysis of saliva reveals disease-associated microbiota in patients with
periodontitis and dental caries. NPJ Biofilms Microbiomes 2017, 3, 23. [CrossRef]
223. Duran-Pinedo, A.E.; Frias-Lopez, J. Beyond microbial community composition: Functional activities of the oral microbiome in
health and disease. Microbes Infect. 2015, 17, 505–516. [CrossRef]
224. Jagtap, P.; McGowan, T.; Bandhakavi, S.; Tu, Z.J.; Seymour, S.; Griffin, T.J.; Rudney, J.D. Deep metaproteomic analysis of human
salivary supernatant. Proteomics 2012, 12, 992–1001. [CrossRef]
225. Takahashi, N.; Washio, J.; Mayanagi, G. Metabolomics of supragingival plaque and oral bacteria. J. Dent. Res. 2010, 89, 1383–1388.
[CrossRef]
226. Edlund, A.; Yang, Y.; Yooseph, S.; Hall, A.P.; Nguyen, D.D.; Dorrestein, P.C.; Nelson, K.E.; He, X.; Lux, R.; Shi, W.; et al. Meta-omics
uncover temporal regulation of pathways across oral microbiome genera during in vitro sugar metabolism. ISME J. 2015, 9,
2605–2619. [CrossRef] [PubMed]
227. Edlund, A.; Garg, N.; Mohimani, H.; Gurevich, A.; He, X.; Shi, W.; Dorrestein, P.C.; McLean, J.S. Metabolic fingerprints from
the human oral microbiome reveal a vast knowledge gap of secreted small peptidic molecules. mSystems 2017, 2, e00058-17.
[CrossRef] [PubMed]
Microorganisms 2024, 12, 121 42 of 45
228. Axelsson, P.; Lindhe, J. The effect of a plaque control program on gingivitis and dental caries in schoolchildren. J. Dent. Res. 1977,
56, C142–C148. [CrossRef]
229. Marsh, P.D. In sickness and in health-what does the oral microbiome mean to us? An ecological perspective. Adv. Dent. Res. 2018,
29, 60–65. [CrossRef] [PubMed]
230. Loesche, W.J.; Bradbury, D.R.; Woolfolk, M.P. Reduction of dental decay in rampant caries individuals following short-term
kanamycin treatment. J. Dent. Res. 1977, 56, 254–265. [CrossRef]
231. de Paola, P.F.; Jordan, H.V.; Berg, J. Temporary suppression of Streptococcus mutans in humans through topical application of
vancomycin. J. Dent. Res. 1974, 53, 108–114. [CrossRef]
232. Li, Y.; Tanner, A. Effect of antimicrobial interventions on the oral microbiota associated with early childhood caries. Pediatr. Dent.
2015, 37, 226–244.
233. Huang, X.; Schulte, R.M.; Burne, R.A.; Nascimento, M.M. Characterization of the arginolytic microflora provides insights into pH
homeostasis in human oral biofilms. Caries Res. 2015, 49, 165–176. [CrossRef]
234. Koopman, J.E.; Roling, W.F.; Buijs, M.J.; Sissons, C.H.; ten Cate, J.M.; Keijser, B.J.; Crielaard, W.; Zaura, E. Stability and resilience
of oral microcosms toward acidification and Candida outgrowth by arginine supplementation. Microb. Ecol. 2015, 69, 422–433.
[CrossRef] [PubMed]
235. Yoo, S.; Murata, R.M.; Duarte, S. Antimicrobial traits of tea- and cranberry-derived polyphenols against Streptococcus mutans.
Caries Res. 2011, 45, 327–335. [CrossRef] [PubMed]
236. de Sousa, D.L.; Araujo Lima, R.; Zanin, I.C.; Klein, M.I.; Janal, M.N.; Duarte, S. Effect of twice-daily blue light treatment on
matrix-rich biofilm development. PLoS ONE 2015, 10, e0131941. [CrossRef] [PubMed]
237. Twetman, S.; Dhar, V. Evidence of Effectiveness of Current Therapies to Prevent and Treat Early Childhood Caries. Pediatr. Dent.
2015, 37, 246–253.
238. O’Mullane, D.M.; Baez, R.J.; Jones, S.; Lennon, M.A.; Petersen, P.E.; Rugg-Gunn, A.J.; Whelton, H.; Whitford, G.M. Fluoride and
oral health. Community Dent. Health 2016, 33, 69–99. [PubMed]
239. Slade, G.D.; Grider, W.B.; Maas, W.R.; Sanders, A.E. Water fluoridation and dental caries in U.S. children and adolescents. J. Dent.
Res. 2018, 97, 1122–1128. [CrossRef] [PubMed]
240. Allukian, M., Jr.; Carter-Pokras, O.D.; Gooch, B.F.; Horowitz, A.M.; Iida, H.; Jacob, M.; Kleinman, D.V.; Kumar, J.; Maas, W.R.;
Pollick, H.; et al. Science, politics, and communication: The case of community water fluoridation in the US. Ann. Epidemiol. 2018,
28, 401–410. [CrossRef]
241. Kilian, M.; Larsen, M.J.; Fejerskov, O.; Thylstrup, A. Effects of fluoride on the initial colonization of teeth in vivo. Caries Res. 1979,
13, 319–329. [CrossRef]
242. van Loveren, C.; Gerardu, V.A.; Sissons, C.H.; van Bekkum, M.; ten Cate, J.M. Effect of various rinsing protocols after use of amine
fluoride/stannous fluoride toothpaste on the bacterial composition of dental plaque. Caries Res. 2009, 43, 462–467. [CrossRef]
243. Hamilton, I.R. Effects of fluoride on enzymatic regulation of bacterial carbohydrate metabolism. Caries Res. 1977, 11 (Suppl. S1),
262–291. [CrossRef]
244. Marquis, R.E.; Clock, S.A.; Mota-Meira, M. Fluoride and organic weak acids as modulators of microbial physiology. FEMS
Microbiol. Rev. 2003, 26, 493–510. [CrossRef] [PubMed]
245. Hamilton, I.R. Biochemical effects of fluoride on oral bacteria. J. Dent. Res. 1990, 69, 660–667, discussion 682–663. [CrossRef]
246. Bowden, G.H. Effects of fluoride on the microbial ecology of dental plaque. J. Dent. Res. 1990, 69, 653–659, discussion 682–653.
[CrossRef] [PubMed]
247. Bradshaw, D.J.; Marsh, P.D.; Hodgson, R.J.; Visser, J.M. Effects of glucose and fluoride on competition and metabolism within
in vitro dental bacterial communities and biofilms. Caries Res. 2002, 36, 81–86. [CrossRef]
248. Ahumada Ostengo, M.d.C.; Wiese, B.; Nader-Macias, M.E. Inhibitory effect of sodium fluoride and chlorhexidine on the growth
of oral lactobacilli. Can. J. Microbiol. 2005, 51, 133–140. [CrossRef] [PubMed]
249. Twetman, S.; Mattiasson, A.; Varela; Bratthall, D. Mutans streptococci in saliva and dental caries in children living in a high and a
low fluoride area. Oral Microbiol. Immunol. 1990, 5, 169–171. [CrossRef] [PubMed]
250. Marinho, V.C.; Chong, L.Y.; Worthington, H.V.; Walsh, T. Fluoride mouthrinses for preventing dental caries in children and
adolescents. Cochrane Database Syst. Rev. 2016, 7, CD002284. [CrossRef] [PubMed]
251. Thurnheer, T.; Belibasakis, G.N. Effect of sodium fluoride on oral biofilm microbiota and enamel demineralization. Arch. Oral Biol.
2018, 89, 77–83. [CrossRef]
252. Koopman, J.E.; van der Kaaij, N.C.; Buijs, M.J.; Elyassi, Y.; van der Veen, M.H.; Crielaard, W.; Ten Cate, J.M.; Zaura, E. The effect of
fixed orthodontic appliances and fluoride mouthwash on the oral microbiome of adolescents—A randomized controlled clinical
trial. PLoS ONE 2015, 10, e0137318. [CrossRef]
253. Reilly, C.; Rasmussen, K.; Selberg, T.; Stevens, J.; Jones, R.S. Biofilm community diversity after exposure to 0.4% stannous fluoride
gels. J. Appl. Microbiol. 2014, 117, 1798–1809. [CrossRef]
254. Reilly, C.; Goettl, M.; Steinmetz, M.; Nikrad, J.; Jones, R.S. Short-term effects of povidone iodine and sodium fluoride therapy on
plaque levels and microbiome diversity. Oral Dis. 2016, 22, 155–161. [CrossRef] [PubMed]
255. Marinho, V.C.; Worthington, H.V.; Walsh, T.; Clarkson, J.E. Fluoride varnishes for preventing dental caries in children and
adolescents. Cochrane Database Syst. Rev. 2013, 7, CD002279. [CrossRef] [PubMed]
Microorganisms 2024, 12, 121 43 of 45
256. Lawrence, H.P.; Binguis, D.; Douglas, J.; McKeown, L.; Switzer, B.; Figueiredo, R.; Laporte, A. A 2-year community-randomized
controlled trial of fluoride varnish to prevent early childhood caries in Aboriginal children. Community Dent. Oral Epidemiol. 2008,
36, 503–516. [CrossRef] [PubMed]
257. Holve, S. An observational study of the association of fluoride varnish applied during well child visits and the prevention of
early childhood caries in American Indian children. Matern. Child Health J. 2008, 12 (Suppl. S1), 64–67. [CrossRef]
258. Weintraub, J.A.; Ramos-Gomez, F.; Jue, B.; Shain, S.; Hoover, C.I.; Featherstone, J.D.; Gansky, S.A. Fluoride varnish efficacy in
preventing early childhood caries. J. Dent. Res. 2006, 85, 172–176. [CrossRef] [PubMed]
259. American Academy of Pediatric Dentistry. Guideline on caries-risk assessment and management for infants, children, and
adolescents. Pediatr. Dent. 2016, 38, 142–149.
260. Paul, S.; Baranya Shrikrishna, S.; Suman, E.; Shenoy, R.; Rao, A. Effect of fluoride varnish and chlorhexidine-thymol varnish
on mutans streptococci levels in human dental plaque: A double-blinded randomized controlled trial. Int. J. Paediatr. Dent./Br.
Paedodontic Soc. Int. Assoc. Dent. Child. 2014, 24, 399–408. [CrossRef] [PubMed]
261. Paek, A.E.; Li, Y.; Wang, Z.; So, P.; Janal, M.N.; Herman, N.G.; Hopkins, A.; Chinn, C. Caries outcome following an intensive
fluoride varnish treatment regimen for children at high risk for early childhood caries. Int. J. Paediatr. Dent./Br. Paedodontic Soc.
Int. Assoc. Dent. Child. 2018, 28, 291–299. [CrossRef]
262. Ramos-Gomez, F.J.; Gansky, S.A.; Featherstone, J.D.; Jue, B.; Gonzalez-Beristain, R.; Santo, W.; Martinez, E.; Weintraub, J.A.
Mother and youth access (MAYA) maternal chlorhexidine, counselling and paediatric fluoride varnish randomized clinical trial
to prevent early childhood caries. Int. J. Paediatr. Dent./Br. Paedodontic Soc. Int. Assoc. Dent. Child. 2012, 22, 169–179. [CrossRef]
263. Lobo, P.L.; de Carvalho, C.B.; Fonseca, S.G.; de Castro, R.S.; Monteiro, A.J.; Fonteles, M.C.; Fonteles, C.S. Sodium fluoride and
chlorhexidine effect in the inhibition of mutans streptococci in children with dental caries: A randomized, double-blind clinical
trial. Oral Microbiol. Immunol. 2008, 23, 486–491. [CrossRef]
264. Weinstein, P.; Spiekerman, C.; Milgrom, P. Randomized equivalence trial of intensive and semiannual applications of fluoride
varnish in the primary dentition. Caries Res. 2009, 43, 484–490. [CrossRef] [PubMed]
265. Berger, T.J.; Spadaro, J.A.; Chapin, S.E.; Becker, R.O. Electrically generated silver ions: Quantitative effects on bacterial and
mammalian cells. Antimicrob. Agents Chemother. 1976, 9, 357–358. [CrossRef] [PubMed]
266. Gao, S.S.; Zhang, S.; Mei, M.L.; Lo, E.C.; Chu, C.H. Caries remineralisation and arresting effect in children by professionally
applied fluoride treatment—A systematic review. BMC Oral Health 2016, 16, 12–21. [CrossRef] [PubMed]
267. Crystal, Y.O.; Niederman, R. Evidence-based dentistry update on silver diamine fluoride. Dent. Clin. N. Am. 2019, 63, 45–68.
[CrossRef] [PubMed]
268. Llodra, J.C.; Rodriguez, A.; Ferrer, B.; Menardia, V.; Ramos, T.; Morato, M. Efficacy of silver diamine fluoride for caries reduction
in primary teeth and first permanent molars of schoolchildren: 36-month clinical trial. J. Dent. Res. 2005, 84, 721–724. [CrossRef]
[PubMed]
269. Liu, B.Y.; Lo, E.C.; Chu, C.H.; Lin, H.C. Randomized trial on fluorides and sealants for fissure caries prevention. J. Dent. Res. 2012,
91, 753–758. [CrossRef] [PubMed]
270. Tan, H.P.; Lo, E.C.; Dyson, J.E.; Luo, Y.; Corbet, E.F. A randomized trial on root caries prevention in elders. J. Dent. Res. 2010, 89,
1086–1090. [CrossRef]
271. Rosenblatt, A.; Stamford, T.C.; Niederman, R. Silver diamine fluoride: A caries “silver-fluoride bullet”. J. Dent. Res. 2009, 88,
116–125. [CrossRef]
272. Suzuki, T.; Sobue, S.; Suginaka, H. Mechanism of antiplaque action of diamine silver fluoride. J. Osaka Univ. Dent. Sch. 1976, 16,
87–95.
273. Hiraishi, N.; Yiu, C.K.; King, N.M.; Tagami, J.; Tay, F.R. Antimicrobial efficacy of 3.8% silver diamine fluoride and its effect on root
dentin. J. Endod. 2010, 36, 1026–1029. [CrossRef]
274. Knight, G.M.; McIntyre, J.M.; Craig, G.G.; Mulyani; Zilm, P.S.; Gully, N.J. Inability to form a biofilm of Streptococcus mutans on
silver fluoride- and potassium iodide-treated demineralized dentin. Quintessence Int. 2009, 40, 155–161. [PubMed]
275. Knight, G.M.; McIntyre, J.M.; Craig, G.G.; Mulyani; Zilm, P.S.; Gully, N.J. Differences between normal and demineralized dentine
pretreated with silver fluoride and potassium iodide after an in vitro challenge by Streptococcus mutans. Aust. Dent. J. 2007, 52,
16–21. [CrossRef] [PubMed]
276. Chu, C.H.; Mei, L.; Seneviratne, C.J.; Lo, E.C. Effects of silver diamine fluoride on dentine carious lesions induced by Streptococcus
mutans and Actinomyces naeslundii biofilms. Int. J. Paediatr. Dent./Br. Paedodontic Soc. Int. Assoc. Dent. Child. 2012, 22, 2–10.
[CrossRef]
277. Mei, M.L.; Li, Q.L.; Chu, C.H.; Lo, E.C.; Samaranayake, L.P. Antibacterial effects of silver diamine fluoride on multi-species
cariogenic biofilm on caries. Ann. Clin. Microbiol. Antimicrob. 2013, 12, 4. [CrossRef] [PubMed]
278. Hamama, H.H.; Yiu, C.K.; Burrow, M.F. Effect of silver diamine fluoride and potassium iodide on residual bacteria in dentinal
tubules. Aust. Dent. J. 2015, 60, 80–87. [CrossRef] [PubMed]
279. Yu, O.Y.; Zhao, I.S.; Mei, M.L.; Lo, E.C.M.; Chu, C.H. Caries-arresting effects of silver diamine fluoride and sodium fluoride on
dentine caries lesions. J. Dent. 2018, 78, 65–71. [CrossRef] [PubMed]
280. Marinho, V.C.; Worthington, H.V.; Walsh, T.; Chong, L.Y. Fluoride gels for preventing dental caries in children and adolescents.
Cochrane Database Syst. Rev. 2015, 6, CD002280. [CrossRef]
Microorganisms 2024, 12, 121 44 of 45
281. Walsh, T.; Worthington, H.; Glenny, A.; Appelbe, P.; Marinho, V.; Shi, X. Fluoride toothpastes of different concentrations for
preventing dental caries in children and adolescents. Cochrane Database Syst. Rev. 2010, 1, CD007868. [CrossRef]
282. Rugg-Gunn, A. Dental caries: Strategies to control this preventable disease. Acta Med. Acad. 2013, 42, 117–130. [CrossRef]
283. Yamaga, R.; Nishino, M.; Yoshida, S.; Yokomizo, I. Diammine silver fluoride and its clinical application. J. Osaka Univ. Dent. Sch.
1972, 12, 1–20.
284. Sinha, N.; Gupta, A.; Logani, A.; Shah, N. Remineralizing efficacy of silver diamine fluoride and glass ionomer type VII for
their proposed use as indirect pulp capping materials—Part II (A clinical study). J. Conserv. Dent. 2011, 14, 233–236. [CrossRef]
[PubMed]
285. Mei, M.L.; Lo, E.C.M.; Chu, C.H. Arresting dentine caries with silver diamine fluoride: What’s behind it? J. Dent. Res. 2018, 97,
751–758. [CrossRef] [PubMed]
286. Li, Y.; Liu, Y.; Psoterc, W.J.; Nguyena, O.M.; Bromage, T.G.; Walters, M.A.; Hu, B.; Rabieh, S.; Kumararaja, F.C. ORIG Assessment
of the silver penetration and distribution in carious lesions of deciduous teeth treated with silver diamine fluoride. Caries Res.
2019, 53, 431–440. [CrossRef]
287. Crystal, Y.O.; Marghalani, A.A.; Ureles, S.D.; Wright, J.T.; Sulyanto, R.; Divaris, K.; Fontana, M.; Graham, L. Use of silver diamine
fluoride for dental caries management in children and adolescents, including those with special health care needs. Pediatr. Dent.
2017, 39, 135–145. [CrossRef] [PubMed]
288. Clemens, J.; Gold, J.; Chaffin, J. Effect and acceptance of silver diamine fluoride treatment on dental caries in primary teeth. J.
Public Health Dent. 2018, 78, 63–68. [CrossRef] [PubMed]
289. Holtz, R.D.; Souza Filho, A.G.; Brocchi, M.; Martins, D.; Duran, N.; Alves, O.L. Development of nanostructured silver vanadates
decorated with silver nanoparticles as a novel antibacterial agent. Nanotechnology 2010, 21, 185102. [CrossRef] [PubMed]
290. Hernandez-Sierra, J.F.; Ruiz, F.; Pena, D.C.; Martinez-Gutierrez, F.; Martinez, A.E.; Guillen Ade, J.; Tapia-Perez, H.; Castanon,
G.M. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomed. Nanotechnol.
Biol. Med. 2008, 4, 237–240. [CrossRef] [PubMed]
291. Dos Santos, V.E., Jr.; Filho, A.V.; Ribeiro Targino, A.G.; Pelagio Flores, M.A.; Galembeck, A.; Caldas, A.F., Jr.; Rosenblatt, A. A New
“Silver-Bullet” to treat caries in children—Nano Silver Fluoride: A randomised clinical trial. J. Dent. 2014, 42, 945–951. [CrossRef]
292. de Castro, D.T.; Valente, M.L.; da Silva, C.H.; Watanabe, E.; Siqueira, R.L.; Schiavon, M.A.; Alves, O.L.; Dos Reis, A.C. Evaluation
of antibiofilm and mechanical properties of new nanocomposites based on acrylic resins and silver vanadate nanoparticles. Arch.
Oral Biol. 2016, 67, 46–53. [CrossRef]
293. de Castro, D.T.a.; do Nascimento, C.; Alves, O.L.; de Souza Santos, E.; Agnelli, J.A.M.; Dos Reis, A.C. Analysis of the oral
microbiome on the surface of modified dental polymers. Arch. Oral Biol. 2018, 93, 107–114. [CrossRef]
294. Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; Chinwalla, H.H.; Creasy, H.H.; Earl, A.M.; FitzGerald, M.G.;
Fulton, R.S.; et al. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214.
295. Keeney, K.M.; Yurist-Doutsch, S.; Arrieta, M.C.; Finlay, B.B. Effects of antibiotics on human microbiota and subsequent disease.
Annu. Rev. Microbiol. 2014, 68, 217–235. [CrossRef]
296. Taubman, M.A.; Nash, D.A. The scientific and public-health imperative for a vaccine against dental caries. Nat. Rev. Immunol.
2006, 6, 555–563. [CrossRef] [PubMed]
297. Batista, M.T.; Ferreira, E.L.; Pereira, G.S.; Stafford, P.; Maeda, D.; Rodrigues, J.F.; Brady, L.J.; Johnston, S.A.; Ferreira, L.C.S.;
Ferreira, R.C.C. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual
vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine 2017, 35, 7273–7282. [CrossRef] [PubMed]
298. Jiang, H.; Hu, Y.; Yang, M.; Liu, H.; Jiang, G. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally
delivered by attenuated Salmonella typhimurium. Immunobiology 2017, 222, 730–737. [CrossRef]
299. St Michael, F.; Yang, Q.; Cairns, C.; Vinogradov, E.; Fleming, P.; Hayes, A.C.; Aubry, A.; Cox, A.D. Investigating the candidacy
of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen
Streptococcus mutans. Glycoconj. J. 2018, 35, 53–64. [CrossRef] [PubMed]
300. Weintraub, J.A.; Hilton, J.F.; White, J.M.; Hoover, C.I.; Wycoff, K.L.; Yu, L.; Larrick, J.W.; Featherstone, J.D. Clinical trial of a
plant-derived antibody on recolonization of mutans streptococci. Caries Res. 2005, 39, 241–250. [CrossRef] [PubMed]
301. Szafranski, S.P.; Winkel, A.; Stiesch, M. The use of bacteriophages to biocontrol oral biofilms. J. Biotechnol. 2017, 250, 29–44.
[CrossRef]
302. Hoare, A.; Marsh, P.D.; Diaz, P.I. Ecological therapeutic opportunities for oral diseases. Microbiol. Spectr. 2017, 5, 10-1128.
[CrossRef]
303. Philip, N.; Suneja, B.; Walsh, L.J. Ecological approaches to dental caries prevention: Paradigm shift or shibboleth? Caries Res. 2018,
52, 153–165. [CrossRef]
304. Lopez-Lopez, A.; Camelo-Castillo, A.; Ferrer, M.D.; Simon-Soro, A.; Mira, A. Health-associated niche inhabitants as oral probiotics:
The case of Streptococcus dentisani. Front. Microbiol. 2017, 8, 379. [CrossRef] [PubMed]
305. Burne, R.A. Getting to know “the known unknowns”: Heterogeneity in the oral microbiome. Adv. Dent. Res. 2018, 29, 66–70.
[CrossRef] [PubMed]
306. Gruner, D.; Paris, S.; Schwendicke, F. Probiotics for managing caries and periodontitis: Systematic review and meta-analysis. J.
Dent. 2016, 48, 16–25. [CrossRef]
Microorganisms 2024, 12, 121 45 of 45
307. Garcia, S.S.; Blackledge, M.S.; Michalek, S.; Su, L.; Ptacek, T.; Eipers, P.; Morrow, C.; Lefkowitz, E.J.; Melander, C.; Wu, H. Targeting
of Streptococcus mutans biofilms by a novel small molecule prevents dental caries and preserves the oral microbiome. J. Dent. Res.
2017, 96, 807–814. [CrossRef] [PubMed]
308. Ren, Z.; Cui, T.; Zeng, J.; Chen, L.; Zhang, W.; Xu, X.; Cheng, L.; Li, M.; Li, J.; Zhou, X.; et al. Molecule targeting glucosyltransferase
inhibits Streptococcus mutans biofilm formation and virulence. Antimicrob. Agents Chemother. 2016, 60, 126–135. [CrossRef]
309. Chen, L.; Jia, L.; Zhang, Q.; Zhou, X.; Liu, Z.; Li, B.; Zhu, Z.; Wang, F.; Yu, C.; Zhang, Q.; et al. A novel antimicrobial peptide
against dental-caries-associated bacteria. Anaerobe 2017, 47, 165–172. [CrossRef]
310. Ding, Y.; Wang, W.; Fan, M.; Tong, Z.; Kuang, R.; Jiang, W.; Ni, L. Antimicrobial and anti-biofilm effect of Bac8c on major bacteria
associated with dental caries and Streptococcus mutans biofilms. Peptides 2014, 52, 61–67. [CrossRef]
311. Saputo, S.; Faustoferri, R.C.; Quivey, R.G., Jr. Vitamin D compounds are bactericidal against Streptococcus mutans and target the
bacitracin-associated efflux system. Antimicrob. Agents Chemother. 2018, 62, e01675-17. [CrossRef]
312. Eckert, R.; Qi, F.; Yarbrough, D.K.; He, J.; Anderson, M.H.; Shi, W. Adding selectivity to antimicrobial peptides: Rational design of
a multidomain peptide against Pseudomonas spp. Antimicrob. Agents Chemother. 2006, 50, 1480–1488. [CrossRef]
313. Eckert, R.; He, J.; Yarbrough, D.K.; Qi, F.; Anderson, M.H.; Shi, W. Targeted killing of Streptococcus mutans by a pheromone-guided
“smart” antimicrobial peptide. Antimicrob. Agents Chemother. 2006, 50, 3651–3657. [CrossRef]
314. Sullivan, R.; Santarpia, P.; Lavender, S.; Gittins, E.; Liu, Z.; Anderson, M.H.; He, J.; Shi, W.; Eckert, R. Clinical efficacy of
a specifically targeted antimicrobial peptide mouth rinse: Targeted elimination of Streptococcus mutans and prevention of
demineralization. Caries Res. 2011, 45, 415–428. [CrossRef] [PubMed]
315. Guo, L.; McLean, J.S.; Yang, Y.; Eckert, R.; Kaplan, C.W.; Kyme, P.; Sheikh, O.; Varnum, B.; Lux, R.; Shi, W.; et al. Precision-guided
antimicrobial peptide as a targeted modulator of human microbial ecology. Proc. Natl. Acad. Sci. USA 2015, 112, 7569–7574.
[CrossRef] [PubMed]
316. Kaplan, C.W.; Sim, J.H.; Shah, K.R.; Kolesnikova-Kaplan, A.; Shi, W.; Eckert, R. Selective membrane disruption: Mode of action of
C16G2, a specifically targeted antimicrobial peptide. Antimicrob. Agents Chemother. 2011, 55, 3446–3452. [CrossRef] [PubMed]
317. Yang, Y.; Reipa, V.; Liu, G.; Meng, Y.; Wang, X.; Mineart, K.P.; Prabhu, V.M.; Shi, W.; Lin, N.J.; He, X.; et al. pH-sensitive
compounds for selective inhibition of acid-producing bacteria. ACS Appl. Mater. Interfaces 2018, 10, 8566–8573. [CrossRef]
[PubMed]
318. Horev, B.; Klein, M.I.; Hwang, G.; Li, Y.; Kim, D.; Koo, H.; Benoit, D.S. pH-activated nanoparticles for controlled topical delivery
of farnesol to disrupt oral biofilm virulence. ACS Nano 2015, 9, 2390–2404. [CrossRef] [PubMed]
319. Gao, L.; Liu, Y.; Kim, D.; Li, Y.; Hwang, G.; Naha, P.C.; Cormode, D.P.; Koo, H. Nanocatalysts promote Streptococcus mutans biofilm
matrix degradation and enhance bacterial killing to suppress dental caries in vivo. Biomaterials 2016, 101, 272–284. [CrossRef]
320. Liu, Y.; Huang, Y.; Kim, D.; Ren, Z.; Oh, M.J.; Cormode, D.P.; Hara, A.T.; Zero, D.T.; Koo, H. Ferumoxytol nanoparticles target
biofilms causing tooth decay in the human mouth. Nano Lett. 2021, 21, 9442–9449. [CrossRef]
321. Selwitz, R.H.; Ismail, A.I.; Pitts, N.B. Dental caries. Lancet 2007, 369, 51–59. [CrossRef]
322. Divaris, K. Predicting dental caries outcomes in children: A “risky” concept. J. Dent. Res. 2016, 95, 248–254. [CrossRef]
323. Tanner, A.C.; Kressirer, C.A.; Faller, L.L. Understanding caries from the oral microbiome perspective. J. Calif. Dent. Assoc. 2016,
44, 437–446. [CrossRef]
324. Flemming, H.C.; Wingender, J.; Szewzyk, U.; Steinberg, P.; Rice, S.A.; Kjelleberg, S. Biofilms: An emergent form of bacterial life.
Nat. Rev. Microbiol. 2016, 14, 563–575. [CrossRef] [PubMed]
325. Koo, H.; Allan, R.N.; Howlin, R.P.; Stoodley, P.; Hall-Stoodley, L. Targeting microbial biofilms: Current and prospective therapeutic
strategies. Nat. Rev. Microbiol. 2017, 15, 740–755. [CrossRef] [PubMed]
326. Belda-Ferre, P.; Williamson, J.; Simon-Soro, A.; Artacho, A.; Jensen, O.N.; Mira, A. The human oral metaproteome reveals potential
biomarkers for caries disease. Proteomics 2015, 15, 3497–3507. [CrossRef] [PubMed]
327. Teng, F.; Yang, F.; Huang, S.; Bo, C.; Xu, Z.Z.; Amir, A.; Knight, R.; Ling, J.; Xu, J. Prediction of early childhood caries via
spatial-temporal variations of oral microbiota. Cell Host Microbe 2015, 18, 296–306. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.